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Programmed cell death (apoptosis) is a genetically regulated form of cell 
death characterized by obvious morphological changes such as cell shrinkage, 
nuclear breakdown, DNA fragmentation and membrane blebbing in all metazoans. 
In favor of the development of the organism as a whole, apoptosis plays an 
important role in elimination of unwanted or harmful cells. Apoptosis is well 
regulated by a series of molecular and biochemical events, of which mitochondria 
contribute most. The way of mitochondrial involvement in apoptosis includes two 
crucial events, the release of pro-apoptotic proteins stored in the mitochondrial 
intermembrane space including cytochrome c and the onset of dissipation of 
mitochondrial membrane potential (⊿ψm). The dissipation of ⊿ψm suggests of 
the occurrence of the mitochondrial permeability transition (MPT). Release of 
cytochrome c triggers a post-mitochondrial pathway forming an oligomeric 
complex of cytochrome c/Apaf-1/caspase-9, the apoptosome which activates the 
executor caspase-3 and subsequently leads to cell death by apoptosis. The MPT 
plays crucial role in regulation of cytochrome c release. Deregulation of the MPT 
leads to pathogenesis of many diseases such as cancer, autoimmune syndromes, 
and neurodegenerative processes. 
This thesis shows that ER stress induced by the Ca2+-ATPase inhibitor 
thapsigargin (THG) activates cytochrome c-dependent apoptosis through 
cooperation between Bax and the mitochondrial permeability transition (MPT) in 
human leukemic CEM cells. Pharmacological inhibition of the MPT as well as 
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small interfering RNA (siRNA) knockdown of the MPT core component 
cyclophilin D blocked cytochrome c release and caspase-dependent apoptosis but 
did not prevent Bax translocation to mitochondria. siRNA knockdown of Bax also 
blocked THG-mediated cytochrome c release and apoptosis, but did not prevent 
MPT activation and resulted in caspase-independent cell death. Our results show 
that ER-stress-induced cell death involves a caspase and Bax-dependent pathway 
as well as a caspase-independent MPT-directed pathway. 
The molecular structure of the MPT pore remains uncertain and recent 
studies have shown that the MPT controls Bcl-2-independent cell death. The 
studies described in this thesis show that the endoplasmic reticulum (ER)-stress 
induces co-release of the profusion GTPase OPA1, which regulates cristae 
junction integrity, and cytochrome c from mitochondria. The MPT is required for 
this co-release since siRNA knocking down cyclophilin-D (Cyp-D) blocks it 
indicating that the MPT controls release of cytochrome c via cristae remodeling 
regulation. The MPT is regulated by functional electron transport chain (ETC) 
since respiratory deficient cells inhibit the release of OPA1/ cytochrome c from 
mitochondria and thereby block apoptosis. These results show that Cyp-D 
dependent MPT requires a functional ETC to regulate the co-release of OPA1 and 
cytochrome c during ER-stress induced apoptosis. 
In conclusion, the MPT plays a crucial role in regulating cytochrome c 
release. By investigating the factors that affect the MPT, we hope to establish a 
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ROLE AND REGULATION OF MITOCHONDRIAL 





1.1 Initiation of apoptosis by two pathways 
Programmed cell death (apoptosis) is a genetically regulated form of cell death 
characterized by obvious morphological changes such as cell shrinkage, nuclear 
breakdown, DNA fragmentation and membrane blebbing in all metazoans. (Tittel 
et al., 2000) These morphological changes are mediated by characteristic 
molecular and biochemical events occurring in an apoptotic cell, most notably the 
activation of cysteine proteases called caspases which eventually mediate the 
cleavage of DNA into oligonucleosomal fragments as well as the cleavage of a 
multitude of specific protein substrates which usually determine the integrity and 
shape of the cytoplasm or organelles (Saraste et al., 2000). In favour of the 
development of the organism as a whole, programmed cell death plays an 
important role in elimination of unwanted or harmful cells. During development 
many cells are produced in excess which eventually undergo programmed cell 
death and thereby contribute to sculpturing many organs and tissues (Meier et al., 
2000). Programmed cell death is a highly regulated event, whose alteration by 
excess or defect leads to pathogenesis of many diseases such as cancer, 
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autoimmune syndromes, and neurodegenerative processes (Reed, 2002; Mullauer 
et al., 2001).  
 
Apoptosis is regulated by two pathways which are extrinsic pathway and intrinsic 
pathway, respectively. Extrinsic apoptosis pathway is mediated by the activation 
of death receptors on the cell surface. (Naismith et al., 1998) On binding with 
specific ligands, these death receptors are activated by oligomerization and then 
amplify apoptotic signals through the formation of death inducing signaling 
complex (DISC) with adapter molecules like FADD and TRADD. After formation, 
the procaspase-8 is recruited to the DISC which leads to autocatalytic activation of 
procaspase-8 and release of active caspase-8. Active caspase-8 then activates 
downstream effector caspases which subsequently cleave downstream substrates 
resulting in programmed cell death. Cells possessing the capacity to induce direct 
and mainly caspase-dependent apoptosis pathways were classified into so called 
type I cells. (Scaffidi et al., 1998) In type II cells, the activation of death receptors 
on the cell surface could not generate apoptotic signals strong enough to initiate 
the activation of caspases cascade for the execution of cell death. In this case, the 
signals need to be amplified via mitochondria-dependent apoptotic pathway which 
is so called intrinsic apoptotic pathway that links caspase signaling cascade and 
mitochondria with the help of Bcl-2 family members (Luo et al., 1998).   
 
1.2 Consequences of mitochondrial permeability 
 3
transition (MPT) 
In addition to amplifying and mediating death receptor apoptotic signaling 
pathway, mitochondria also play a pivotal role in the integration and propagation 
of death signals coming from inside the cell (Kaufmann et al., 2000). Most of 
these death signals result in the disruption of the mitochondrial membrane 
potential (⊿Ψm) and the mitochondrial permeability transition (MPT). MPT 
refers to the transition of mitochondrial inner membrane permeability caused by 
[Ca2+] overload or oxidative stress in in vitro conditions. (Haworth and Hunter, 
1979; Woodfield et al., 1998; Crompton et al., 1998; Crompton et al., 1999; 
Zoratti and Szabo, 1995 and Brustovetsky and Klingenberg, 1996). Pfeiffer and 
co-workers proposed that the MPT was caused by the activation of mitochondrial 
phospholipase A2 with the evidence that trifluoperazine which inhibits 
phospholipase A2, could attenuate the MPT in vitro (Pfeiffer et al., 1989). 
 
In contrast to Pfeiffer’s idea, Haworth and Hunter in 1979 when they first found 
the phenomena of the MPT proposed that it was caused by the opening of a 
regulable pore structure (Haworth and Hunter 1979). The MPT pore theory was 
supported by several lines of independent evidence. First, when isolated 
mitochondrial were exposed to [Ca2+] and phosphate they showed a sharp cut-off 
in permeability to poly(ethylene glycol) with molecular weight up to 1.5KDa 
(Hawoth and Hunter 1979) consistent with the induction of a large pore whose 
radius was later measured by rapid-pulsed flow technique to be 1.3 nm (Crompton 
 4
and costi 1990). Since the radius of poly(ethylene glycol) 1.5 KDa was about 1.2 
nm (Ginsburg and Stein 1987), the two sets of methods made very close 
measurements. Second, was the finding that the MPT was inhibited by 
cyclosporine A (CsA) and its nonimmunosuppressant analogue 
N-Met-Val-4-cyclosporine A (Crompton et al., 1988; Broekemeier et al., 1989; 
Davidson et al., 1990; Nicolli et al., 1996). This indicates that the MPT can be 
regulated by the interaction between the pore structure and drugs. Third, the 
patch-clamp technique found that a pore structure endowed with a 
high-conductance channel is located at the mitochondrial inner membrane 
(Sorgato et al., 1987). This channel was known as mitochondrial megachannel 
(MMC) which is inhibited by CsA indicating that the MMC was the MPT pore.  
 
The direct consequence of the MPT is the depolarization of mitochondrial 
membrane potential (MMP) and collapse of the proton gradient. Different 
durations of the pore opening seem to be a key regulator to determine the 
consequences of the MPT (Petronilli et al., 2001). Transient and reversible 
opening of the MPT pore is believed to have physiological functions (Hunter et al., 
1976). Persistent PT pore opening leads to the decline of ATP due to the loss of 
proton gradient which powers the synthesis of ATP by F1F0-ATPase. In order to 
maintain the MMP, mitochondrial ATPase hydrolyzes ATP resulting in more 
depletion of ATP. This pathological consequence of the MPT was first reported to 
be related with ischemia-reperfusion disease in the late 1980s (Crompton et al., 
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1987; Crompton et al., 1990). Since then, many studies have proved this idea and 
revealed that the MPT would be a therapeutic target for myocardial protection 
(Halestrap et al., 2004).   
 
Besides resulting in loss of ATP, persistent MPT pore opening causes the swelling 
of the mitochondrial matrix by allowing water and solutes less than 1500 Da to 
cross inner membrane freely. As the surface area of inner membrane is larger than 
that of outer membrane, the swelling of mitochondrial matrix ruptures the outer 
membrane mechanically. The rupture of the outer membrane facilitates the release 
of inter membrane proapoptotic proteins into cytosol, including cytochrome c 
(Petit et al., 1998). Upon release into cytosol, cytochrome c binds to apoptotic 
protease activating-factor 1(Apaf-1), an action that increases 10-fold affinity 
between Apaf-1 and dATP resulting in the formation of apoptosome. After 
formation, the apoptosome promotes Apaf-1 to expose its caspase-recruitment 
domain (CARD) which recruits and cleaves procaspase-9 leading to the release of 
active caspase-9. Active caspase-9 activates downstream executioner caspases 
which cleave specific substrates and induce apoptosis (Liu et al., 1996).  In 
addition to the release of inter-membrane proapoptotic factors, the dissipation of 
MMP also brings about the depletion of redox molecules such as pyridine 
nucleotides (PN) (Vinogradov et al., 1972) and generation of reactive oxygen 
species (ROS). These cause increased oxidative stress which induces the oxidation 
of lipids, proteins, and nucleic acids, thereby in turn enhancing the dissipation of 
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MMP to form a positive feedback loop (Kroemer et al., 2000). 
Interestingly, the MPT is always followed by loss of membrane potential, but loss 
of membrane potential is not always caused by MPT, and cytochrome c release 
has been observed even in absence of loss of membrane potential [Bernardi, 1999; 
Kroemer, 2000]. In addition to the release of mitochondrial factors, the dissipation 
of Dy and PT also cause a loss of the biochemical homeostasis of the cell: ATP 
synthesis is stopped, redox molecules such as NADH, NADPH, and glutathione 
are oxidized, and reactive oxygen species (ROS) are increasingly generated 
[Kroemer, 2000; Kroemer, 1997]. Increased levels of ROS directly cause the 
oxidation of lipids, proteins, and nucleic acids, thereby enhancing the disruption 
of Dy as part of a positive feedback [Marchetti, 1997]. 
 
1.3 The MPT pore components 
1.3.1 Role of the adenine nucleotide translocator (ANT)  
It has been suggested that regulation of the ANT by specific ligands is correlated 
to the opening or closure of the MPT. The ANT, which serves to import ADP into 
mitochondria and to export ATP into cytosol flickers between two conformational 
states while interacting with nucleotides. Atractylate, which activates the MPT, 
inhibits the ANT and stabilizes it in the cytosolic state (c-state); while bongkrekic 
acid, which inhibits the MPT, inhibits the ANT but stabilizes it in the matrix state 
(m-state) indicating c-state conformation of the ANT is required for the activation 
of the MPT (Le Quoc et al., 1988).  
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Many other features of the ANT are similar to the behaviors of the MPT pore. 
First, when incorporated into liposomes, the ANT converts into a non-selective 
high-conductance channel in the presence of high concentration of [Ca2+] 
(Brustovetsky et al., 1996). This high conductance was inhibited on removal of 
[Ca2+] in line with the character of the MPT. Second, in planar lipid membranes 
the conductance of the ANT-derived pore was completely inhibited at pH=5.2, 
which also occurs in the regulation of the MPT pore. Third, the ANT-derived pore 
in reconstituted system showed reversal gated property when the current-voltage 
is in the range of 150 mV and 180 mV, which is consistent with the hypothesis 
that the modulation of the MPT is dependent on membrane potential (Bernardi, 
1999). Taken together, these lines of evidence suggested that the ANT is one 
component of the MPT pore structure.  
 
However, a recent study using genetic techniques put the idea that the ANT is a 
MPT structural component into doubt. Mitochondria isolated from ANT genetic 
knockout mice still responded to the stimuli of [Ca2+] and the MPT of ANT-null 
mitochondria was fully inhibited by CsA, indicating that the ANT is not essential 
for the occurrence of the MPT (Kokoszka et al., 2004). The results obtained with 
the ANT knockout mice raised an intriguing question, however. If such animals 
live normal and healthy lives without the energy communication between cytosol 
and mitochondria facilitated by the ANT, a function which is the primary function 
possessed by the ANT, what benefit does the ANT bestow that has led to its 
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conservation through evolution? An alternative explanation suggested that 
undetectable residual ANT was present or other carrier family members 
substituted for the ANT (Halestrap, 2004).  
 
1.3.2 Role of the voltage-dependent anion channel 
(VDAC) 
The VDAC is located at the outer membrane and permeable to solutes and 
metabolites less than 5 KDa, thereby allowing free exchange of electron transport 
chain substrates such as NADH, FADH and ATP/ADP between inter-membrane 
space and cytosol. Besides facilitating exchange of mitochondrial metabolites, the 
VDAC is also implicated in the MPT phenomena (Le Quoc et al., 1985). First, 
when reconstituted into planar phospholipid bilayers, the VDAC dimerizes and 
forms a channel that exhibits electrophysiological properties including voltage 
dependence, pH dependence and selectivity, reminiscent of those of the MPT pore 
(Szabó et al., 1993). Second, the VDAC, when incorporated into liposomes, 
displays permeability to molecular cut-off size regulated by [Ca2+] which is also 
the major stimuli of the MPT pore (Bathori et al., 2006). Similarly, NADH which 
is a modulator of the MPT pore also regulates the gating of the VDAC (Zizi et al., 
1994). Third, cyclophilin D (CyP-D) fusion protein, when used as the affinity 
matrix, purified the VADC and the ANT forming a polyprotein complex whose 
permeability was stimulated by [Ca2+] and phosphate and inhibited by CsA 
consistent with the properties of the MPT pore (Crompton et al., 1998). 
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Although these studies suggest that the VDAC should be involved as structural 
component of the MPT pore, they are based on behaviors of the VDAC in 
liposomes in vitro resembling those of the MPT pore. Cesura and colleagues 
identified a inhibitor of the MPT pore after a high screening study, namely Ro 
68-3400 when used as a probe in intact isolated mitochondria targeted a 32 KDa 
protein thought to be the isoform 1 of the VDAC (VDAC1) (Cesura et al., 2003). 
However, it was recently shown that the mitochondria isolated from 
VDAC1-knockout mice also corresponded to the MPT inhibition by Ro 68–3400 
illustrating that the 32 KDa targeted protein was not VDAC1 (Krauskopf et al., 
2006). The difficulty of genetic knockout of all the VDAC isoforms derives from 
the fact that the unconditional elimination of the VDAC2 leads to embryonic 
lethality. Therefore, the screening of high affinity pharmacological inhibitors that 
specifically target all the VDAC isoforms will show the conclusive evidence of 
the role of the VDAC in the occurrence of the MPT phenomena.  
 
1.3.3 Role of the cyclophilin D (CyP-D) 
CyP-D is a mitochondrial matrix protein belonging to the family of cyclophilin 
proteins that catalyze the cis-trans isomerization of proline amino acid peptide 
bonds in proteins resulting in conformational changes. Several lines of evidence 
suggested the role of CyP-D as a MPT pore component. (a), the first evidence 
used to support the involvement of the CyP-D in the MPT pore was based on the 
discovery that CsA, which inhibited the activation of the MPT also inhibited the 
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peptidylprolyl cis-trans isomerase (PPIase) activity of the CyP-D in the similar 
range of concentrations (McGuinness et al., 1990; Helestrap and Davidson, 1990). 
(b), a photoactive CsA derivate, when used in photolabelling experiment, 
identified a 21 KDa PPIase protein which was later sequenced to be CyP-D, 
indicating that the CyP-D was the target protein of CsA when it blocked the MPT 
pore activation (Andreeva et al., 1995; Tanveer et al., 1996). (c), it is anticipated 
that a soluble protein like CyP-D playing a role in the activation of the MPT it 
must interact with other components of the MPT pore and induce conformational 
changes by its PPIase activity. In 1998, Halestrap’s team and Crompton’ team, 
respectively, found that the activation of the MPT pore was facilitated by the 
interaction between the CyP-D and the ANT under the [Ca2+] or oxidative stress 
(Halestrap et al., 1998; Crompton et al., 1998). Taken with these observations, the 
MPT pore has been described as the VDAC located at the outer membrane and the 
ANT located at the inner membrane form the complex at the contact sites and the 
CyP-D regulates the flickering state of the ANT between open state and close state 
via its PPIase activity in the presence of high [Ca2+] and/or oxidative stress 
(Desagher and Martinou , 2000). 
 
One of the potential problems determining the CyP-D to be a component of the 
MPT pore structure is that CsA, when displaying the capability to inhibit the MPT 
probably has multiple actions and is not specific. For example, besides binding to 
the cyclophilin family members, CsA also binds to other proteins including actin, 
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heat shot protein 70 (HSP70) and especially to calcineurin (Fruman et al., 1992; 
Moss et al., 1992; Khaspekov et al., 1999). Calcineurin is found to affect 
mitochondrial function through the activation of BAD by dephosphorylation 
leading to release of the proapoptotic proteins stored in the mitochondria (Wang et 
al., 1999).  Inhibition of calcineurin is a kind of immunosuppressive effects of 
CsA, which comes from the Ca2+-calmodulin dependent inhibition of calcineurin 
by the complex of CsA with cytosolic CyP-A (Liu et al., 1991). However, several 
lines of evidence illustrated that calcineurin does not participate in the inhibitory 
effects of CsA on the MPT because some analogues of CsA have been indicated 
that inhibit the MPT pore, but do not inhibit calcineurin activity (Clarke et al., 
2002; Hansson et al., 2004).  
 
Recent genetic studies provided a line of conclusive evidence convincing the role 
of CyP-D in modulation of the MPT through knocking out the Ppif gene, which 
encodes CyP-D protein (Baines et al., 2005; Nakagawa et al., 2005). In these 
studies, mitochondria isolated from CyP-D deficient mice significantly raised the 
threshold for the activation of the MPT stimulated by [Ca2+], in a manner 
reminiscent of that of CsA-treated mitochondria isolated from wild-type mouse. 
Moreover, CsA has no effect on the CyP-D null mice mitochondria indicating that 
CyP-D is the mitochondrial target for CsA. However, a higher [Ca2+] 
concentration overcame the resistance of the null CyP-D mitochondria leading to 
the activation of the MPT, illustrating that CsA is an anatognist of the MPT rather 
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than an inhibitor. Based on these findings, it appears to be more accurate to 
describe the role of the CyP-D as it is a regulator of the MPT not a component, 
because the MPT pore can form and open without CyP-D.  
 
1.3.4 Role of peripheral benzodiazepine receptor (PBR) 
and hexokinase (HK) and creatine kinase (CK) 
The PBR is a hydrophobic 18 KDa protein located at the mitochondrial outer 
membrane and was initially found to be the benzodiazepines binding site (Anholt 
et al., 1986). The PBR is found to be abundant in cells producing steroid 
hormones including adrenal cortex and Leydig cells of the testis, and the primary 
function of the PBR in these cells is to facilitate the transport of cholesterol into 
mitochondrial matrix, which is a rate-limiting step in the steroid synthesis (De 
Souza et al., 1985; Papadopoulos et al., 1997). The first data pointing to the 
involvement of the PBR in regulation of the MPT was isolation of the PBR with 
reversible ligand binding technique, which indicated that the PBR interacts 
allosterically with the VDAC and the ANT (McEnery., et al., 1992). However, 
contradictory results came out when the PBR ligands were tested aiming at 
finding the exact role of the PBR in the MPT. Some studies pointed out that the 
PBR ligands promoted the opening of the MPT pore (Hirsch et al., 1998; 
Pastorino et al., 1994). Other studies, in contrast, indicated that the PBR ligands 
inhibited the opening of the MPT pore (Leducq et al., 2003). These obvious 
discrepancies can be explained from differences in cell types. On the other hand, it 
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also illustrated that the role of the PBR in the MPT is still not clear. 
 
The mitochondria-bound HK with two isoforms, HK-I and HK-II, serves as a 
primary function to catalyze the ATP-dependent phosphorylation of glucose to 
produce glucose-6-phosphate, which controls the fist step of glucose metabolism 
and subsequently couples glycosis in the cytosol to oxidative phosphorylation in 
the mitochondria (Robey and Hay, 2006). Distribution of the HK at mitochondrial 
surface or preferentially at “contact sites” between outer membrane and inner 
membrane was suggested by electron microscope technique following removal of 
the unattached outer membrane (Weiler et al., 1985; Dorbani et al., 1987). The 
involvement of the HK in the MPT was implicated following the detergent 
isolation of the HK, which associated with the protein of the VDAC and the ANT 
in a manner of tetramer to form a complex with characterization of physiological 
conductance (i.e. asymmetrical and voltage dependent) (Beutner et al., 1996). 
Majewski and coworkers proposed that the association of the HK and the VDAC 
helps to inhibit the MPT and release of cytochrome c, and the dissociation of the 
HK from the mitochondria leads to mitochondrial swelling and apoptosis 
(Majewski et al., 2004). Similarly, Azoulay-zohar and colleagues found that direct 
interaction of HK-I with the VDAC, resulting in the closure of the VDAC channel, 
prevented the [Ca2+]-mediated opening of the MPT pore and release of 
cytochrome c (Azoulay-zohar et al., 2004). In addition, the role of HK-II in 
inhibition of the MPT pore was found to compete for the binding of Bax to the 
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VDAC, which disrupts the pro-apoptotic role of Bax on the induction of the MPT 
(Pastorina et al., 2002). 
 
Creatine kinase (CK) plays a central role in controlling the cellular energy 
homeostasis. The CK builds up a reversible interchange of creatine and 
phosphocreatine pool to provide a temporal and spatial buffer for ATP levels, 
especially in tissues with high and fluctuating energy requirement such as muscle 
and brain (Schlattner et al., 1998). Mitochondrial creatine kinase (mtCK) forms a 
octameric microcompartment located at contact sites between inner and outer 
mitochondrial membrane facilitating production and export of phosphocreatine 
into cytosol (Dolder et al., 2001). Surface plasmon resonance spectroscopy 
technique revealed that octameric mtCK specifically interacts with the VDAC and 
this specific interaction was regulated by ionic strength (Schlattner et al., 2001).  
The involvement of the mtCK in the MPT was demonstrated following a in vitro 
reconstitution experiment, which showed resistance to the stimuli of the MPT 
when incorporating octameric mtCK into the complex of the VDAC and ANT 
(O’Gorman et al., 1997). Recently, the inhibition of the MPT by mtCK was found 
to be dependent on the activity of the mtCK in the presence of mtCK substrates, 
suggested that mitochondrial creatine kinase activity located within the 
intermembrane and intercristae space, in conjunction with its tight functional 
coupling to mitochondrial oxidative phosphorylation, via the adenine nucleotide 
translocase, can regulate the opening of the MPT pore in the presence of creatine 
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(Dolder et al., 2003). 
 
Unfortunately, much of the data used to support the role of the HK and CK in 
modulation of the MPT is based on tenuous logical generalization – 
characterization of the HK or the CK in isolation in vitro conditions correspond to 
the stimuli of the MPT observed in mitochondria, thereby the HK or the CK must 
be part of the MPT. Until the genetic work was carried out in in vivo conditions, 
the conclusive result can be obtained. 
 
1.4 Regulation of the MPT 
1.4.1 Regulation of the MPT by electron transport chain 
(ETC)  
The MPT can be modulated by substantial factors, among them is matrix pH. In 
1992, Bernardi and coworkers found that matrix acidification induced by nigericin 
added to mitochondria, attenuates the activation of the MPT induced by 
phenylarsine oxide which is independent of [Ca2+] (Bernardi et al., 1992), 
indicating that the MPT pore is voltage dependent and involves the proton 
pumping modulated by electron transport chain (ETC). The inhibitory effect of 
lowering matrix pH was demonstrated following the proof of the strong MPT 
inducer inorganic phosphate whose effect can be attributed to increasing matrix 
pH (Lapidus et al., 1994). In 1998, Bernardi’s team gave further evidence with 
detail showing the presence of the ETC in regulation of the MPT (Fontaine et al., 
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1998a). They proposed that when complex I of the ETC is provided the electron 
donor substrate for energization, the MPT was much easier to be stimulated by 
lower mitochondrial [Ca2+] loads, and this increased sensitivity was exclusively 
based on how fast electron flows through complex I which is the first enzyme of 
the ETC with the function of oxidative phosphorylation (OXPHOS) suggesting 
that the ETC may involve in the modulation of the MPT. In agreement with the 
MPT regulation by electron flow, the same group also identified a common 
binding site of complex I by ubiquinone analogues of which ubiquinone 0 and 
decylqubquinone show inhibitory effect on the MPT, whereas 
OH-decylubiquinone is a inducer of the MPT indicating allosterical interaction 
between ubiquinone derivatives and complex I binding site is essential for the 
regulation the MPT (Fontaine et al., 1998b; Walter et al., 2000).  
 
In addition to complex I, complex III was also found to be involved in modulation 
of the MPT. In 2002, Armstrong and coworkers showed that electron transport 
chain inhibitors stigmatellin and antimycin A, which inhibit Qo and Qi sites of 
complex III of the ETC respectively, preserved the redox state of the mitochondria, 
blocked the generation of mitochondrial reactive oxygen species (ROS), and 
prevented loss of MMP and opening of the MPT, indicating that the activity of the 
mitochondrial complex III of the ETC is a new site in regulating the MPT 
(Armstrong et al., 2002). Although in his work ROS, which is also an inducer of 
the MPT by oxidative impairment of the integrity of the mitochondrial membrane, 
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complex III as a regulator of the MPT can not be excluded. More recently, when 
utilizing proteomics techniques to analyze isolated rat liver mitochondria 
incubated with MPT inducers, Rieske iron-sulfur protein (RISP) of 
ubiquinol-cytochrome c reductase (Complex III) was suggested to be involved in 
the form of dephosphorylation which was blocked by pretreatment with CsA, 
indicating that dephosporylation of the RISP a part of the MPT (He and Lemasters, 
2005).  
 
Actually, ρ0 cells (mitochondrial DNA deficient cells) can be utilized as a useful 
tool to study the role of the functional ETC as a whole in modulation of the MPT. 
The respiratory proteins are encoded by nuclear DNA and mitochondrial DNA 
(mtDNA). Human mtDNA is a circular molecule of 16,569 base pairs that encodes 
13 polypeptide components of the electron transport chain, as well as the rRNAs 
and tRNAs necessary for intramitochondrial protein synthesis using its own 
genetic code, in which mtDNA encodes 7 subunits of complex I 
(NADH-ubiquinone reductase), 1 subunit of complex III (ubiquinal-cytochrome c 
reductase), 3 subunits of complex IV (cytochrome c oxidase) and 2 subunits of 
complex V (ATP synthase), so depletion of mtDNA leads to dysfunction of the 
whole ETC (Anderson et al., 1981). Some data showed that the inhibitory effect of 
CsA on the MPT is related to suppression of uncoupling of mitochondria by CsA, 
indicating OXPHOS coupling mediated by the ETC plays a role in the MPT 
(Amerkhanov., 1996). Recently, it has been reported that disruption of MMP and 
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release of cytochrome c in keratinocytes and human 143B parental cells induced 
by anthralin, an anti-psoriatic drug was blocked in keratinocytes and human 143B 
ρ0 cells (McGill et al., 2005), consistent with the importance of the ETC in other 
apoptotic stimuli (Lee et al., 2004; Park et al.,  2004). In contrast, results 
obtained from other experiments employing mtDNA-depleted (ρ0) cells indicated 
that ρ0 cells responded to a number of apoptotic signals as efficiently as their 
parental cells (Jacobson et al., 1993; Marchetti et al., 1996). So the underlying 
mechanism of the ETC in the role of the MPT is still controversial, investigation 
on this topic is valuable to be carried out, and since the ETC plays a fundamental 
role in energy yield by OXPHOS in human cells, it is logical to hypothesize that 
the functional ETC also plays some role in regulation of the MPT. 
 
1.4.2 Regulation of the MPT by redox stress 
Mitochondria are not only the site for the generation of the reactive oxygen 
species (ROS) but also a target of ROS which stimuli the opening of the MPT 
pore by oxidation-dependent mechanism. The first finding indicating that the MPT 
was regulated by redox state of mitochondria was oxidation of pyridine 
nucleotides (PN), which could be inhibited or reversed by NAD(P)+ reduction 
(Lehninger et al., 1978). An interesting line of evidence of the link between the 
MPT and NAD(P) redox status is demonstrated following inhibition of the MPT 
via maintenance of reduced PN (Kowaltowski et al., 2000). Mitochondrial 
membrane potential (MMP) controls the opening of the MPT pore which is 
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sensitive to lower intramitochondrial [Ca2+] as MMP decreases (Catisti and 
Vercesi, 1999). So the regulation of the MPT by NAD(P) redox status is probably 
mediated by the effects of MMP changes on the NAD(P) redox status, which is 
regulated by NADP transhydrogenase (Hoek and Rydstrom, 1988).  
 
In addition to PN oxidation, thiol oxidation is another site regulating the opening 
of the MPT pore. In 1994, Petronilli and colleagues when testing the mechanism 
whereby oxidants affected the opening of the MPT found that either thiol oxidants 
(such as diamide) or cross-linkers (such as phenylarsine oxide) promoted the 
opening of the MPT pore (Petronilli et al., 1994). Both diamide and phenylarsine 
oxide are sulfhydryl group reagents which either convert the dithiols to disulfides 
by the function of diamide or form a covalent bond between thiol atom and 
arsenite atom by the function of phenylarsine oxide, which is reversibly inhibited 
by dithiothreitol(DTT). In this case it was suggested that protein vicinal thiols 
(PVT) are involved, indicating that protein conformational change caused by 
thiol-disulfide interconversion are involved in the occurrence of the MPT. Based 
on the above analysis, we now know that the MPT was not only regulated by 
intramitochondrial [Ca2+] but also by PN oxidation and GSH pool redox 
(Chernyak and Bernardi, 1996). 
  
In 1997, it was proposed that two independent modes were involved in 
modulation of the MPT that were “sensitive” and “insensitive” to CyP-D and both 
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modes were experimentally supported (Scarrano et al., 1997). This observation 
was critical to the alternative explanation for the MPT which proposed that the 
MPT was not caused by specific interactions between heterogeneous native 
mitochondrial proteins, but caused by non-specific oxidation damage to inner 
membrane proteins which compromised the integrity of the inner membrane. 
Actually, similar work was already presented in the early 1990 to show that [Ca2+] 
plus pro-oxidants promoted the aggregation of beef heart submitochondrial 
particles resulting in damage of the integrity of the inner membrane (Fagian et al., 
1990). Since then, accumulative evidence suggested that the MPT was the result 
of non-specific aggregation of pre-existing mitochondrial inner membrane protein 
by oxidative stress rather than the result of opening of a preformed pore (Gadelha 
et al., 1997; Vercesi et al., 1997; Kowaltowski et al., 2001). In 2002, He and 
Lemasters proposed a new mode of MPT namely “unregulated” MPT to explain 
the observation that in some cases the MPT was not inhibited by CsA (He and 
Lemasters, 2002). He and Lemasters suggested that the “unregulated” MPT occurs 
when misfolded inner membrane proteins caused by oxidative stress exceed the 
ability of chaperone proteins. 
 
1.4.3 Regulation of the MPT by Bcl-2 family members 
The Bcl-2 family proteins, which reside upstream of mitochondria play central 
role in regulation of apoptosis by integrating substantial survival and death signals 
generated from the outside or the inside of the cells (Adams and Cory, 2001). 
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Bcl-2 family proteins possess α–helix conserved sequence motifs known as Bcl-2 
homology (BH) domains. Anti-apoptotic members such as Bcl-2 and Bcl-xL 
exhibit all the four conserved motifs from BH1 to BH4. Bcl-2 is a membrane 
associated protein whose hydrophobic C-terminal domain facilitates them target 
cytoplasmic face of intracellular membranes including mitochondrial outer 
membrane, endoplasmic reticulum (ER) membrane and nuclear envelope. A main 
approach to inhibit apoptosis of Bcl-2 is to bind BH3 domains of proapoptotic 
Bcl-2 members using its hydrophobic groove formed by BH1, BH2 and BH3 
domains (Reed, 1998). Overexpression of Bcl-2 or Bcl-xL preserves viability from 
cytotoxic insults such as generation of ROS (Hockenbery et al., 1993).  
 
The proapoptotic Bcl-2 members can further be subdivided into two groups: the 
BH3-only proteins such as Bim, Bmf, Bad, Bid, PUMA and Noxa etc which have 
only the BH3 conserved motif, whereas multidomain proteins such as Bax and 
Bak which display conserved motifs in BH1, BH2 and BH3. BH3-only proteins 
are held inert by various mechanisms to prevent accidental cell death during 
development. Bim and Bmf are kept inactive state by sequestering with dynein 
light chains that Bim binds to microtubules and Bmf binds to actin cytoskeleton 
(Puthalakath et al., 1999; Puthalakath et al., 2001).  Bad is sequestered to 14-3-3 
scaffold proteins after phosphorylation at serine residues by Akt or protein kinase 
A with the supply of growth factor (Zha et al., 1996). If growth factors are 
withdrawn, Bad is activated and released from its anchor protein by 
 22
de-phosphorylation approach which is probably mediated by calcineurin (Wang et 
al., 1999). Bid is synthesized as a precursor and thus relatively inactive in cells 
until proteolysis cleavage, whereas PUMA and Noxa are regulated at 
transcriptional level induced by transcription factor p53 in response to DNA 
damage (Nakano et al., 2001; Oda et al., 2000).  
 
In response to diverse intrinsic or extrinsic apoptotic stimuli, BH3-only proteins 
are activated by one or several above-mentioned post-translational modifications 
from proteolysis cleavage to dephosphorylation. Following activation, individual 
BH3-only proteins sense and transduce death signals specifically downstream to 
mitochondria. Under the stimuli of cellular damage by UV-irradiation, BimL is 
unleashed from its docker protein which enables it to bind to antiapoptotic Bcl-2 
proteins, thereby neutralizing them. Similarly after dephosphorylation, Bad 
promotes cell death by binding to Bcl-xL which inhibits the pro-survival function 
of Bcl-xL (Kelekar et al., 1997).  Actually most BH3-only proteins, including 
Bad, Bim, Noxa and Bik, in response to apoptotic stimuli, show a binding 
preference for antiapoptotic Bcl-2 family members rather than multidomain 
proteins (Borner, 2003). By neutralizing antiapoptotic Bcl-2 family members, 
these BH3-only proteins release multidomain proteins such as Bax and Bak which 
either interact with mitochondrial proteins or form channel-like structure to 
mediate proapoptotic factors release from mitochondria.  
However, Bid displays multiple approaches to promote cell death and 
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N-myristoylation of cleaved Bid on p15 enhances the efficiency of Bid in 
inducing cell death and cytochorme c release (Zha et al., 2000). Many hypotheses 
have been put forth to explain the mechanism whereby Bid exerts its biological 
functions. Lutter et al., proposed that cardiolipin located at contact sites between 
outer membrane and inner membrane recruits the tBid to target to the 
mitochondria, subsequently inducing cytochrome c release (Lutter et al., 2000). 
Consistent with this, Bid was also reported to induce cristae reorganization, 
following binding to cardiolipin, which leads to release of cytochrome c (Kim et 
al., 2004). This function is independent of BH3 domain but can be inhibited by 
cardiolipin specific dye, 10-N-nonyl acridine orange, indicating that the MPT 
might somehow relate to cristae remodeling. Other data indicated that truncated 
Bid (tBid) activated multidomain proteins including Bax and Bak, resulting in 
their oligomerization to form a pore-like structure for cytochrome c efflux thus 
linking death signals to cell demise (Eskes et al., 2000; Wei et al., 2000). In 2002, 
Scorrano and coworkers reported that recombinant tBid, when added to isolated 
mitochondria fraction, induced mitochondrial cristae remodeling and subsequently 
release of cytochrome c independent of multidomain protein Bak (Scorrano et al., 
2002). Although this function of tBid does not require function of its BH3 domain, 
its role in causing mitochondrial cristae fusion and cristae junctions widening is 
sensitive to CsA, reminiscent of the involvement of the MPT in cristae 
remodeling.  
As BH3-only proteins can efficiently induce cell death via a variety of functions 
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such as neutralizing anti-apoptotic Bcl-2 family members, activating multidomain 
proteins or directly causing release of pro-apoptotic factors from mitochondria, 
understanding their regulation may provide novel therapeutic strategy in clinical 
application. Inhibitors of BH3-only proteins may prevent degenerative disorders, 
whereas drugs mimicking pro-death BH3 domain will provide a good approach to 
restore apoptosis mechanism in cancer cells or autoimmune disease (Cory and 
Adams, 2005; Wang et al., 2000). 
 
Multidomain proteins, Bax and Bak, are believed to be key regulators in apoptosis, 
for cells lacking Bax and Bak do not involve permeabilization of outer 
mitochondrial membrane, or demise in response to a variety of apoptotic insults 
(Wei et al., 2001).  Bax is a cytosolic monomer in healthy cells where it is kept 
inactive by being sequestered to non Bcl-2 proteins including humanin, Ku70 and 
14-3-3 isoforms (Nomura et al., 2003; Guo et al., 2003; Sawada et al., 2003).  
Following apoptotic stress, Bax undergoes conformational change and targets to 
the mitochondria and thereby exposes its N-terminal domains. The release of  
C-terminus from its hydrophobic pocket formed by BH1, BH2 and BH3 domains 
is too essential for Bax membrane fusion (Wolter et al., 1997); when targeting to 
the mitochondria, Bax oligomerizes to form a pore-like structure to allow 
cytochrome c release. However even in healthy cells, Bak attaches to 
mitochondrial outer membrane in an oligomeric form, but it also needs 
conformational changes during apoptosis and facilitate the release of 
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pro-apoptotic factors from mitochondria. VDAC2 was found to bind with inactive 
Bak, representative of one approach to keep Bak inert in resting cells (Cheng et al., 
2003). As suggested that Bax conformation can be further modulated by 
mitochondrial intrinsic proteins following inserting to mitochondrial membrane 
(Zamzami and Kroemer, 2001), it is possible that Bak too utilizes mitochondrial 
resident molecules or be triggered by other apoptosis inducers including BH3-only 
protein and p53 to self-aggregate to larger oligomers within mitochondrial 
membrane (Wei et al., 2000; .Leu et al., 2004). 
 
Bax and Bak are believed to mainly function at mitochondria to mediate 
permeability of mitochondrial outer membrane, allowing the efflux of 
pro-apoptotic factors. However, the mechanism whereby these mulitdomain 
proteins undertake is still elusive. A couple of modes were proposed. One model is 
that Bax and Bak form pore-like structure. This idea is based on that multidomains 
BH1-BH3 can form a channel structure in a manner which resembles membrane 
translocation domain of diphtheria toxin and the colicins (Muchmore et al., 1996).   
Supporting to this idea, recombinant Bax was found to form a pore in liposomes. 
Two molecules of Bax form a pore at 11 Å, however four molecules of Bax form a 
bigger pore at 22 Å which allow efflux of cytochrome c from liposomes, 
indicating that the ability of home-oligomerization to larger aggregates may form 
suitable channel for bigger molecules in mitochondria to release (Saito 2000).  
An alternative mechanism indicated that the biological function exerted by these 
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multidomain proteins involves the MPT. Cumulative evidence points to the 
concept that interaction between Bcl-2 family members and components of the 
MPT modulates the permeabilization of outer and inner mitochondrial membrane 
and mobilization of pro-death factors of mitochondria into cytosol (Zamzami and 
Kroemer, 2001). First, Bax was found to favor the MPT by interacting with the 
ANT. In 1998, Marzo and co-workers reported that Bax cooperates with the ANT 
to enhance the MPT and thereby result in cell death, by using yeast 
two-hybridization and co-immunoprecipitation approaches (Marzo et al., 1998). 
Viral protein R was reported to trigger the permeabilization of membrane 
reconstituted with the ANT in the presence of Bax, which was inhibited by Bcl-2 
(Jacotot et al., 2000).  Second, Bax was found to favor the MPT by interacting 
with the VDAC. Evidence has been obtained suggesting that Bax/Bak mediated 
cytochrome c release from wild type yeast mitochondria not from 
VDAC-deficient yeast mitochondria (Shimizu et al., 1999). This observation 
indicated that interaction between multidomain proteins and the VDAC results in 
opening state of the MPT by increasing the VDAC channel. In addition, BH4 
domain of Bcl-xL was reported to compete with Bax for binding to the VDAC, 
which could close the channel of the VDAC, when reconstituted in liposome 
(Shimizu et al., 2000), even in the presence of Bax, indicating that pro- and 
anti-apoptotic Bcl-2 family members regulate cell death via modulating the MPT 
components.  
1.5 Release of mitochondrial molecules 
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1.5.1 Property of mitochondrial pro-apoptotic proteins 
Following the permeabilization of mitochondrial outer membrane, pro-apoptotic 
proteins stored in the inter membrane space (IMS) are released into cytosol to 
induce cell death by different approaches. They either activate caspases by 
inhibiting caspases inhibitors including Smac/Diablo (second 
mitochondria-derived activator of caspases/ direct IAP binding protein with low pI) 
and Omi/HtrA2 (high temperature requirement protein A2), or directly initiate 
caspase cascade activation including cytochrome c, or result in cell death through 
caspase-independent pathway including apoptosis inducing factor (AIF) and 
endonuclease G (EndoG). 
 
Smac/Diablo, a 25KDa nuclear encoded protein, removes it’s a 55-amino-acid 
N-terminus mitochondrial target sequence after it imports into mitochondria. 
Smac/Diablo binds to BIR (baculavirous IAPs repeats) domain of IAPs (inhibitor 
of apoptosis proteins) through its first four amino acids at N-terminus to counter 
the inhibitory functions of IAPs. (Chai et al., 2000) IAPs are a family of 
anti-apoptotic proteins that contain one or multiple BIR domains which confer 
anti-apoptotic activity of IAPs as BIR domains interact with caspases and thereby 
inhibit them (Deveraux and Reed, 1999). IAPs are certainly important negative 
regulators of cell death, when considered that caspases cascades once activated, 
are irreversible and thereby need be precisely regulated to avoid temporally 
incidental cell death. Contrary to the function of IAPs, Smac/Diablo when 
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released from mitochondrial inter-membrane space, restores caspases activation 
via competition with caspases for the binding with IAPs, which releases caspases 
from IAPs and subsequently leads to activation of caspses. Omi/HtrA2, another 
IAP antagonist, is a mitochondrial serine protease that is also released into cytosol 
in response apoptosis stimuli. Following release, Omi/HtrA2 inactivates IAPs by 
the catalytic cleavage of them using the serine protease domain in the central 
region of the molecule, and PDZ domain located at C-terminal region facilitates 
this protease activity (Yang et al., 2003). 
 
AIF is a 57 KDa flavoprotein that resides in mitochondrial IMS and has conserved 
homology with the bacterial oxidoreductases. When outer mitochondrial 
membrane is breached it translocates to nucleus and causes cell death featuring 
apoptosis including chromatin condensation and DNA fragmentation. The cell 
death induced by the function of AIF is caspase independent as it is not inhibited 
by pan-caspase inhibitor known as zVAD-fmk (Susin et al., 1999). It is not clear 
how AIF cleaves the DNA as AIF itself does not possess DNase activity (Susin et 
al., 1999). Moreover, it was also reported that AIF apoptosis-inducing function 
does not rely on its oxidoreductase activity (Miramar et al., 2001). Similar to the 
AIF, EndoG is also sequestered in the IMS and translocates to nucleus during 
apoptosis. Once activated, EndoG cleaves chromatin DNA into nucleosomal 
fragments which is unrelated to caspase activity (Li et al., 2001). The function of 
AIF and EndoG represents a caspase independent apoptosis originating from 
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mitochondrial impairment. Activation of them initiates a new pathway to 
apoptosis bypassing caspase cascade. 
 
Cytochrome c is encoded by nuclear DNA and imports into mitochondria in a 
specific pathway without the help of mitochondrial membrane potential or the 
guidance of general protein translocation mechanism (Mayer et al., 1995). 
Cytochrome c, component of electron transport chain initiates activation of 
caspase once released into cytosol. Upon release into cytosol, cytochrome c binds 
to apoptotic protease activating-factor 1(Apaf-1) resulting in 10-folds increase of 
binding affinity between Apaf-1 and dATP/ATP (Jiang and Wang, 2000). The 
binding of nucleotide to cytochrome c/Apaf-1 complex leads to the formation of 
apoptosome exposing caspase-recruitment domain (CARD) in Apaf1 and thereby 
the exposed CARD domain recruits procaspase-9 to the apoptosome and 
subsequently induces the efficient cleavage and activation of aspase-9 which 
results in the activation of downstream executioner caspase including caspase-3 
(Wang, 2001) and finally cell demise by apoptosis.  
 
When these pro-apoptotic factors stay inside mitochondria, the cells live when 
they move outside mitochondria, the cells die, so the way to release them must be 
carefully regulated to circumvent unwanted cell death.  
  
1.5.2 Mechanism of cytochrome c release 
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Cytochrome c plays a pivotal role in apoptosis. Therefore, the study of 
cytochrome c release seems as a promising approach in curing many diseases 
especially in anti-cancer therapy, which will sensitize cancer cells to conventional 
chemotherapy and circumvent resistance. Although, several lines of evidence 
indicate that the MPT opening leads to cytochrome c release and subsequently cell 
death by apoptosis (Petit et al., 1998; Liu et al., 1996), the precise mechanism is 
not clear. Two models were proposed to explain how the MPT caused the release 
of cytochrome c. One model suggested that the MPT allows for large amount of 
water and metabolite influx leading to osmotic swelling of matrix which 
eventually results in rupture of mitochondrial outer membrane and release of 
pro-apoptotic proteins including cytochrome c (Petit et al., 1998). Alternatively, 
the other model indicated that swollen mitochondria did not lead to damaged outer 
membrane. Von-Ahsen and coworkers observed that isolated mitochondria from 
HL-60 cells treated with recombinant Bid and Bax proteins liberated cytochrome 
c rapidly but mitochondrial ultrastructure and protein import function were 
preserved illustrating that mitochondrial membrane system was intact (von-Ahsen 
et al., 2000).   
 
To fully understand how cytochrome c is completely released, the mitochondrial 
ultrastructure should be considered. The availability of high-voltage (1000kV) 
electron microscopic (HVEM) tomography allows for observing meaning 3D 
imaging of mitochondrial internal structure and led to remarkable change in our 
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view of mitochondrial structure. In 1994, the first 3D structure of mitochondria 
produced by Mannella et al revealed that, unlike the standard baffle model shown 
in textbooks, the cristae are not simply accordion-like folds (Mannella et al., 
1994). Instead, the cristae are pleiomorphic and sac-like structure and are 
connected by narrow and long tubular regions to each other and to the peripheral 
region of the inner membrane at site known as cristae junction (CJ). The 
pleomorphic cristae compose highly restricted compartments separated from IMS 
by narrow CJ, with average diameters of 28 nm (Frey and Mannella., 2000). This 
shifting view of mitochondrial structure has important implications in our 
understanding apoptosis and cytochrome c release. The majority of cytochrome c 
is believed to be sequestered in the cristae, whilst the minority of cytochrome c is 
stored in the IMS which possesses a narrow space with average distance of 20 nm 
between the outer and inner boundary membranes. 
 
As the tubular cristae are deeply recessed into matrix, cytochrome c has to take a 
long distance to reach CJ before moving into IMS indicating complete release of 
cytochrome c involves cristae remodeling or the MPT-modulated phenomena. The 
successful release of cytochrome c from mitochondria to the cytosol is considered 
to involve the following process: first, cytochrome c is detached from cardiolipin 
and other redox components of the ETC (Orrenius and Zhivotovskv, 2005); then 
cytochrome c mobilizes into IMS following it passes through “widened” CJ which 
is likely caused by cristae remodeling or MPT-mediated mitochondrial swelling 
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(Mannella et al., 2001); the last step of this process involves release of 
cytochrome c into the cytosol via the channel-like structure formed by Bax and 
Bak.  A very recent study has pointed out that complete release of cytochrome c 
from cristae compartment is quite important for the induction of apoptosis, 
because the minority stored in IMS is insufficient to initiate activation of 
apoptosome and subsequent apoptosis. In this study, Tang’s group provides 
convincing evidence showing that accidentally or unwanted release of a small 
amount of cytochrome c has no apoptotic effect because physiological level of 
intracellular nucleotides can neutralize this small amount of cytochrome c through 
electronstatic interaction with Apaf-1 (Changdra et al., 2006). As the 
“multi-domain” proteins serve as the last gate for release of cytochrome c, the 
tightness of cristae junctions control the majority cytochrome c release. 
 
The regulation of cristae remodeling has gained tremendous interest as it is 
important for cytochrome c release and dysfunction of the mitochondria. How 
cristae are remodeled? Cristae remodeling is a kind of cristae membrane structure 
reorganization involving mitochondrial dynamic morphology change controlled 
by a precise balance of mitochondrial fission and fusion. Mitochondrial fission is 
mainly controlled by dynamin-related protein 1 (Drp1). In response to stimuli that 
promote mitochondrial fission, Drp1 translocates from cytosol to mitochondria 
where it interacts with human Fis1 (hFis1) which anchors at outer membrane 
possessing a tetratricopeptide repeat (TPR) domain facing into cytosol (Suzuki et 
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al., 2003). The TPR domain seems to be target site of Drp1. Following binding 
with TPR domain, Drp1 causes mitochondrial division which favors cell death 
(Ingerman et al., 2005). In support of this, Germain et al reported that BH-3 only 
protein BIK induces mitochondrial fragmentation, with the help of Drp1, which 
leads to cristae remodeling and increased cytochrome c egress (Germain et al., 
2005). In this case the Drp1-dependent cristae remodeling and widening is crucial 
for cytochrome c release. Mitochondrial fragmentation during apoptosis is 
controlled by mitochondrial fission machinery, and ablation of Drp1 or hFis1 
prevents mitochondrial fragmentation, and subsequently blocks cytochrome c 
release, and therefore can delay or inhibit the cell death (Lee et al., 2004). 
 
Mitochondrial fusion entails a series of elaborate events regulated by Mitofusin1 
and 2 (Mfn1, Mfn2) and Opa1. Loss of Mfn1 Mfn2 results in remarkable 
reduction in mitochondrial fusion and even lethality. Mfn1 and Mfn2 share up to 
81% homology sequence and therefore both of them are engaged in mediating 
mitochondrial fusion. Structure analysis revealed that at least in Mfn1-regulated 
fusion, adjacent mitochondrial fusion was mediated by homo-oligomerization 
through interactions of heptad repeat region which assemble a dimeric, 
antiparallel coiled coil (Koshiba et al., 2004). However, embryonic fibroblasts 
knocking down Mfn1 or Mfn2 display distinct types of fragmented mitochondria 
indicating that they may have distinct functions (Chen et al., 2003). Mutations in 
Mfn2 result in most cases of Charcot-Marie-Tooth type 2A disease, an inherited 
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peripheral neuropathy (Zuchner et at., 2004). Functional differences also lie in 
how fast they hydrolyze GTP, and Mfn1 display much higher GTPase activity 
which corresponds to much higher homo-oligomers formed by Mfn1 (Ishihara et 
al., 2004). Moreover, mitochondrial fusion was also reported to involve MMP, 
dissipation of which inhibits mitochondrial fusion leading to mitochondrial 
fragmentation and reestablishment of MMPT restores fusion process (Legros et al., 
2002). Of note, dissipation of MMP is a direct consequence of MPT opening, 
suggestive of a manner how the MPT controls mitochondrial morphology.   
 
As mitofusins control outer membrane fusion, inner membrane fusion is 
controlled by another protein, OPA1. OPA1 gene, optic atrophy type 1 gene, has 
been identified as the gene whose mutation is associated with autosomal dominant 
optic atrophy (ADOA), known as type I Kjer disease, affecting retinal ganglion 
cells and leading to progressive blindness due to the loss of these cells (Alexander 
et al., 2000). Mitochondrial from ADOA patients display significant condensed 
indicating mitochondrial disease can be influenced by its morphology imbalance 
(Delettre et al., 2000). OPA1, dynamin-related GTPase protein, is located on the 
mitochondrial inner membrane facing the intermembrane space (Satoh et al., 
2003). Structure analysis indicated that OPA1 contain five different domains, 
mitochondrial target domain, N-terminal coiled-coil domain, GTPase domain, 
dynamin central region and C-terminal coiled-coil domain. The abundant 
coiled-coil domain implicates that protein-protein interactions could be crucial for 
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OPA1 mediated inner membrane fusion process. Actually, OPA1 can be involved 
in both homo-oligomers and hetero-oligomers. The work by Frezza et al. provided 
new insight into the role of OPA1 in cristae remodeling and cytochrome c release. 
They found that OPA1 maintains the tightness of cristae junctions via forming 
hetero-oligomeric complexes between inner membrane bound OPA1 molecules 
and shorter soluble forms of the same protein that are located in the inter 
membrane space (Frezza et al., 2006). Moreover, OPA1 can maintain the integrity 
of cristae junctions and inhibits release of cytochrome c independent of 
mitochondrial fusion events. In support of this, Frezza et al. also provided 
evidence that OPA1 could control the tightness of cristae junctions in cells lacking 
Mfn1 and 2, which are essential for mitochondrial fusion. In another paper in the 
same issue of Cell, Cipolat et al. provide evidence that mitochondrial inner 
membrane rhomboid protease, PARL, is also required for OPA1 function. PARL 
cleaves OPA1 into shorter and soluble forms which are crucial for correct 
assembly of OPA1 hetero-oligomeric complexes (Cipolat et al., 2006).  
 
1.6 Objectives and Significance 
Mitochondrion is an organelle which plays a major role in cellular signaling 
pathways, cellular response to stress and cellular activation of apoptosis. In order 
to investigate these key events of mitochondria, we establish the following three 
major objectives. The first objective is to determine the relationship between Bax 
and the MPT in regulating cytochrome c release and apoptosis during endoplasmic 
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reticulum-mitochondrial calcium signaling. The second objective is to characterize 
the role of functional electron transport chain in regulating the MPT. The third is 
to determine the precise mechanism how the MPT regulates mitochondrial cristae 
remodeling. By pursuing these objectives, we hope to find out the exact role of the 
MPT in cell death and thereby to provide an overview of MPT related 
pathophysiological events. The knowledge of the factors that regulate the MPT 
will certainly promote our understanding of how the MPT leads to these diseases 
and thereby provide a precise therapeutic approach. This thesis represents one of 
the many efforts toward a complete understanding of those molecular events 
governing the MPT.  
 
The clinical significance of this study is that dysfunction of mitochondria and ER 
has been involved in many diseases including heart attack, neurodegeneration and 
especially cancer. The anti-cancer drug thapsigargin (THG) which is the major 
model drug in this study has been shown to effectively kill prostate cancer cells. 
THG is a SERCA-ATPase inhibitor which causes ER stress and increases of 
cellular level of calcium which subsequently enters mitochondria leading to the 
MPT. By this mechanism THG results in activation of ER-stress response and 
simultaneous activation of apoptotic pathways within the ER and the mitochondria. 
The cytotoxicity of THG has been suggested to be useful by coupling to a 
targeting peptide to produce an inactive prodrug that is only activated by prostate 
cancer specific proteases such as the serine protease prostate-specific antigen 
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(PSA). PSA-activated thapsigargin prodrugs have been characterized that are 
selectively toxic to PSA-producing prostate cancer cells in vitro and in vivo. By 
studying the drugs which could induce the MPT including THG, we hope to 





















z Adams JM and Cory S. (2001) Life-or-death decisions by the Bcl-2 protein 
family. Trends Biochem Sci. 26: 61-66. 
z Alexander,C, Votruba.M, Pesch U.E., Thiselton D.L., Mayer S., Moore A., 
Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S.S. and 
Wissinger B. (2000) OPA1, encoding a dynamin-related GTPase, is mutated 
in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 
26: 211–215. 
z Amerkhanov ZG, Yegorova MV, Markova OV and Mokhova EN. (1996) 
Carboxyatractylate- and cyclosporin A- sensitive uncoupling in liver 
mitochondria of ground squirrels during hibernation and arousal. Biochem 
Mol Biol Int. 38(5):863-870. 
z Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, 
Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, 
Young IG. (1981) Sequence and organization of the human mitochondrial 
genome. Nature. 286(5772):460-467. 
z Andreeva L., Tanveer A. and Crompton M.(1995) Evidence for the 
involvement of a membrane-associated cyclosporin-A-binding protein in the 
Ca(2+)-activated inner membrane pore of heart mitochondria. Eur. J. Biochem. 
230:1125–1132. 
 39
z Anholt RR, Pedersen PL, De Souza EB and Snyder SH (1986) The 
peripheral-type benzodiazepine receptor. Localization to the mitochondrial 
outer membrane. J Biol Chem 261: 576 – 583. 
z Armstrong JS and Jones DP. (2002) Glutathione depletion enforces the 
mitochondrial permeability transition and causes cell death in Bcl-2 
overexpressing HL60 cells. FASEB J. 16(10):1263-1265. 
z Azoulay-Zohar H, Israelson A, Abu-Hamad S and Shoshan-Barmatz V. (2004) 
In self-defence: hexokinase promotes voltage-dependent anion channel 
closure and prevents mitochondria-mediated apoptotic cell death. Biochem J. 
377(Pt 2):347-355. 
z Baines CP , Kaiser RA , Purcell NH , Blair NS , Osinska H , Hambleton MA , 
Brunskill EW , Sayen MR , Gottlieb RA , Dorn GW, Robbins J and Molkentin 
JD. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial 
permeability transition in cell death. Nature 434: 658 – 662. 
z Bathori G., Csordas G., Garcia-Perez C., Davies E., and Hajnoczky G. (2006) 
Ca2+-dependent Control of the Permeability Properties of the Mitochondrial 
Outer Membrane and Voltage-dependent Anion-selective Channel (VDAC). J. 
Biol. Chem. 281(25): 17347 - 17358. 
z Bernardi P (1999) Mitochondrial transport of cations: channels, exchangers and 
permeability transition. Physiol Rev 79: 1127 – 1155. 
 40
z Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I and Zoratti M. (1992) 
Modulation of the mitochondrial permeability transition pore. Effect of 
protons and divalent cations. J. Biol. Chem. 267: 2934-2939. 
z Beutner G, Ruck A, Riede B, Welte W and Brdiczka D. (1996) Complexes 
between kinases, mitochondrial porin and adenylate translocator in rat brain 
resemble the permeability transition pore. FEBS letter. 296: 189-195. 
z Borner C. (2003) The Bcl-2 protein family: sensors and checkpoints for 
life-or-death decisions. Mol Immunol. 39(11): 615-647. 
z Broekemeier K.M. and Pfeiffer D.R.. (1989) Cyclosporin A-sensitive and 
insensitive mechanisms produce the permeability transition in mitochondria. 
Biochem. Biophys. Res. Commun. 163: 561–566 
z Broekemeier KM , Dempsey ME and Pfeiffer DR (1989) Cyclosporin A is a 
potent inhibitor of the inner membrane permeability transition in liver 
mitochondria . J Biol Chem.  264:7826 – 7830. 
z Brustovetsky N. and Klingenberg M.(1996) Mitochondrial ADP/ATP carrier 
can be reversibly converted into a large channel by Ca2+. Biochemistry 35: 
8483–8488. 
z Brustovetsky N. and Klingenberg M.. (1996) Mitochondrial ADP/ATP carrier 
can be reversibly converted into a large channel by Ca2+. Biochemistry 35: 
8483–8488. 
 41
z Catisti R and Vercesi A. (1999) The participation of pyridine nucleotides redox 
state and reactive oxygen in the fatty acid-induced permeability transition in 
rat liver mitochondria. FEBS Lett. 464: 97-101. 
z Cesura AM , Pinard E , Schubenel R , Goetschy V , Friedlein A , Langen H , 
Polcic P , Forte MA , Bernardi P and Kemp JA (2003) The voltage-dependent 
anion channel is the target for a new class of inhibitors of the mitochondrial 
permeability transition pore. J Biol Chem 278: 49812 – 49818. 
z Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y. (2000) Structural and 
biochemical basis of apoptotic activation by Smac/DIABLO. Nature. 406: 
855-862. 
z Chandra D, Bratton SB, Person MD, Tian Y, Martin AG, Ayres M, Fearnhead 
HO, Gandhi V and Tang DG. (2006) Intracellular nucleotides act as critical 
prosurvival factors by binding to cytochrome C and inhibiting apoptosome. 
Cell. 125:1333-1346. 
z Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE an Chan DC. (2003) 
Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and 
are essential for embryonic development. J Cell Biol. 160(2):189-200. 
z Cheng EH, Sheiko TV, Fisher JK, Craigen WJ and Korsmeyer SJ. (2003) 
VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science. 
301(5632):513-517. 
z Chernyak, BV and Bernardi, P (1996) The mitochondrial permeability 
transition pore is modulated by oxidative agents through both pyridine 
 42
nucleotides and glutathione at two separate sites. Eur. J. Biochem. 238: 
623–630. 
z Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger 
K, Frezza C, Annaert W, D'Adamio L, Derks C, Dejaegere T, Pellegrini L, 
D'Hooge R, Scorrano L and De Strooper B. (2006) Mitochondrial rhomboid 
PARL regulates cytochrome c release during apoptosis via OPA1-dependent 
cristae remodeling. Cell. 126(1):163-175. 
z Clarke SJ, McStay GP and Halestrap AP. (2002) Sanglifehrin A acts as a potent 
inhibitor of the mitochondrial permeability transition and reperfusion injury 
of the hear by binding to cyclophilin-D at a different site from cyclosporine A. 
J. Biol.Chem. 277: 34793-34799. 
z Cory S and Adams JM. (2005) Killing cancer cells by flipping the Bcl-2/Bax 
switch. Cancer Res. 8: 5-6. 
z Crompton M , Costi A and Hayat L (1987) Evidence for the presence of a 
reversible Ca2+-dependent pore activated by oxidative stress in heart 
mitochondria. Biochem J. 245: 915 – 918. 
z Crompton M , Ellinger H and Costi A (1988) Inhibition by cyclosporin A of a 
Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate 
and oxidative stress . Biochem J 255: 357 – 360 
z Crompton M, Virji S,Ward JM.(1998) Cyclophilin-D binds strongly to 
complexes of the voltage-dependent anion channel and the adenine nucleotide 
 43
translocase to form the permeability transition pore. Eur J Biochem. 
258(2):729-735. 
z Crompton M. and Costi A.. (1990) A heart mitochondrial Ca2(+)-dependent 
pore of possible relevance to re-perfusion-induced injury. Evidence that ADP 
facilitates pore interconversion between the closed and open states. Biochem. 
J. 266:33–39. 
z Crompton M., Virji S. and Ward J.M.. (1998) Cyclophilin-D binds strongly to 
complexes of the voltage-dependent anion channel and the adenine nucleotide 
translocase to form the permeability transition pore. Eur. J. Biochem. 258: 
729–735. 
z Crompton M., Virji S., Doyle V., Johnson N. and Ward J.M. (1999)  The 
mitochondrial permeability transition pore. Biochem. Soc. Symp. 66: 
167–179. 
z Davidson AM and Halestrap AP (1990) Partial inhibition by cyclosporin A of 
the swelling of liver mitochondria in vivo and in vitro induced by 
sub-micromolar [Ca2+], but not by butyrate. Evidence for two distinct 
swelling mechanisms. Biochem J 268:147 – 152. 
z De Souza EB , Anholt RR , Murphy KM , Snyder SH and Kuhar MJ ( 1985 ) 
Peripheral-type benzodiazepine receptors in endocrine organs: 
autoradiographic localization in rat pituitary, adrenal, and testis. 
Endocrinology 116: 567 – 573. 
 44
z Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, 
Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, 
Lasquellec L, Arnaud B, Ducommun B, Kaplan J and Hamel CP. (2000) 
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is 
mutated in dominant optic atrophy. Nat. Genet. 26: 207–210. 
z Desagher S and Martinou JC. (2000) Mitochondria as the central control point 
of apoptosis. Trends Cell Biol. 10(9): 369-377. 
z Deveraux QL and Reed JC. (1999) IAP family proteins--suppressors of 
apoptosis. Genes Dev. 13(3):239-252. 
z Dolder M, Walzel B, Speer O, Schlattner U and Wallimann T. (2003) Inhibition 
of the mitochondrial permeability transition by creatine kinase substrates. 
Requirement for microcompartmentation. J Biol Chem. 
278(20):17760-17766. 
z Dolder M, Wendt S and Wallimann T. (2001) Mitochondrial creatine kinase in 
contact sites: interaction with porin and adenine nucleotide translocase, role in 
permeability transition and sensitivity to oxidative damage. Biol Signals 
Recept. 10(1-2):93-111. 
z Dorbani L,Jancsik V, Linden M, Leterrier JF, Nelson BD and Rendon A. (1987) 
Subfractionation of the outer membrane of rat brain mitochondria: evidence 
for the existence of a domain containing the porin-hexokinase complex. Arch 
Biochem Biophys. 252(1):188-96. 
 45
z Eskes R, Desagher S, Antonsson B and Martinou JC. (2000) Bid induces the 
oligomerization and insertion of Bax into the outer mitochondrial membrane. 
Mol. Cell. Biol. 20: 929-935. 
z Fagian MM, Pereira-da-Silva L, Martins IS and Vercesi AE. (1990) Membrane 
protein thiol cross-linking associated with the permeabilization of the inner 
mitochondrial membrane by Ca2+ plus prooxidants. J Biol Chem. 265: 
19955-19960. 
z Fontaine E, Eriksson O, Ichas F, and Bernardi P. (1998a) Regulation of the 
Permeability Transition Pore in Skeletal Muscle Mitochondria. J Biol. Chem. 
273: 12662-12668. 
z Fontaine E, Ichas F, and Bernardi P. (1998b) A ubiquinone-binding site 
regulates the mitochondrial permeability transition pore. J Biol. Chem. 273: 
25734-25740. 
z Frey TG and Mannella CA. (2000) The internal structure of mitochondria. 
Trends Biochem Sci. 25(7):319-324. 
z Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, 
Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B and Scorrano L. 
(2006) OPA1 controls apoptotic cristae remodeling independently from 
mitochondrial fusion. Cell. 126(1):177-189. 
z Fruman D.A., Klee C.B., Bierer B.E. and Burakoff S.J. (1992) Calcineurin 
phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin 
A. Proc. Natl. Acad. Sci. USA  89:3686–3690. 
 46
z Gadelha FR, Thomson L., Fagian M.M., Costa A.D., Radi R. and Vercesi 
A.E.(1997)  Ca2+-independent permeabilization of the inner mitochondrial 
membrane by peroxynitrite is mediated by membrane protein thiol 
cross-linking and lipid peroxidation. Arch. Biochem. Biophys. 345: 243–250. 
z Germain M, Mathai JP, McBride HM and Shore GC. (2005) Endoplasmic 
reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae 
during apoptosis. EMBO J. 24(8):1546-1556. 
z Ginsburg H and Stein WD. (1987) Biophysical analysis of novel transport 
pathways induced in red blood cell membranes. J Membr Biol. 96(1):1-10.  
z Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC and Reed JC. 
(2003) Humanin peptide suppresses apoptosis by interfering with Bax 
activation. Nature. 423(6938):456-461. 
z Halestrap A.P. (2004) Mitochondrial permeability: dual role for the ADP/ATP 
translocator? Nature 430:1 p following 983. 
z Halestrap A.P. and Davidson A.M. (1990) Inhibition of Ca2(+)-induced 
large-amplitude swelling of liver and heart mitochondria by cyclosporin is 
probably caused by the inhibitor binding to mitochondrial-matrix 
peptidyl-prolyl cis–trans isomerase and preventing it interacting with the 
adenine nucleotide translocase. Biochem. J. 268: 153–160. 
z Halestrap A.P., Kerr P.M., Javadov S. and Woodfield K.Y. (1998) Elucidating 
the molecular mechanism of the permeability transition pore and its role in 
reperfusion injury of the heart. Biochim. Biophys. Acta 1366:79–94. 
 47
z Halestrap AP, Clarke SJ and Javadov SA (2004) Mitochondrial permeability 
transition pore opening during myocardial reperfusion – a target for 
cardioprotection. Cardiovasc Res 61: 372 – 385. 
z Hansson MJ, Mattiasson G, Mansson R, Karlsson J, Keep MF, Waldmeier P, 
Ruegg UT, Dumont JM, Besseghir K and Elmer E ( 2004 ) The 
nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display 
nanomolar potencies on permeability transition in brain-derived mitochondria. 
J Bioenerg Biomembr. 36: 407 – 413. 
z Haworth R.A. and Hunter D.R. (1979) The Ca2+-induced membrane transition 
in mitochondria. II. Nature of the Ca2+ trigger site. Arch. Biochem. Biophys. 
195: 460–467. 
z He L and Lemasters JJ (2002) Regulated and unregulated mitochondrial 
permeability transition pores: a new paradigm of pore structure and function? 
FEBS Lett. 512: 1-7. 
z He L and Lemasters JJ. (2005) Dephosphorylation of the Rieske iron-sulfur 
protein after induction of the mitochondrial permeability transition. Biochem 
Biophys Res Commun. 334: 829-837. 
z Hirsch T , Decaudin D , Susin SA , Marchetti P , Larochette N , Resche-Rigon 
M & Kroemer G (1998) PK11195, a ligand of the mitochondrial 
benzodiazepine receptor, facilitates the induction of apoptosis and reverses 
Bcl-2-mediated cytoprotection. Exp Cell Res. 241: 426 – 434. 
 48
z Hockenbery D.M, Oltvai Z.N, Yin X.-M, Milliman C.L and Korsmeyer 
S.J.(1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. 
Cell 75: 241–251. 
z Hoek JB and Rydstrom J. (1988) Physiological roles of nicotinamide 
nucleotide transhydrogenase. Biochem. J. 254:1–10. 
z Hunter DR , Haworth RA and Southard JH (1976)  Relationship between 
configuration, function, and permeability in calcium-treated mitochondria . J 
Biol Chem. 251: 5069 – 5077. 
z Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, 
and Nunnari J.(2005) Dnm1 forms spirals that are structurally tailored to fit 
mitochondria. J Cell Biol. 170(7):1021-1027. 
z Ishihara N, Fura Y and Mihara K. (2004) Mitofusin 1 and 2 play distinct roles 
in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 117: 
6535-6546  
z Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC and Raff MC. (1993) 
Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 
361:365-369. 
z Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, 
Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, 
Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP and Kroemer G. (2000) 
The HIV-1 viral protein R induces apoptosis via a direct effect on the 
mitochondrial permeability transition pore. J Exp Med. 191(1):33-46. 
 49
z Jiang X and Wang X. (2000) Cytochrome c promotes caspase-9 activation by 
inducing nucleotide binding to Apaf-1. J Biol Chem. 275(40):31199-311203. 
z Kaufmann, SH and Earnshaw, WC (2000). Induction of apoptosis by cancer 
chemotherapy. Exp Cell Res 256(1): 42-49. 
z Kelekar A, Chang BS, Harlan JE, Fesik SW and Thompson CB. (1997) Bad is 
a BH3 domain-containing protein that forms an inactivating dimer with 
Bcl-XL. Mol. Cell Biol. 17: 7040–7046. 
z Khaspekov L., Friberg H., Halestrap A., Viktorov I. and Wieloch T.(1999) 
Cyclosporin A and its nonimmunosuppressive analogue 
N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced 
damage to rat cultured hippocampal neurons. Eur. J. Neurosci. 11: 
3194–3198. 
z Kim TH, Zhao Y, Ding WX, Shin JN, He X, Seo YW, Chen J, Rabinowich H, 
Amoscato AA and Yin XM. (2004) Bid-cardiolipin interaction at 
mitochondrial contact site contributes to mitochondrial cristae reorganization 
and cytochrome C release. Mol Biol Cell. 15(7):3061-3072. 
z Kokoszka JE , Waymire KG , Levy SE , Sligh JE , Cai J , Jones DP , 
MacGregor GR and Wallace DC (2004) The ADP/ATP translocator is not 
essential for the mitochondrial permeability transition pore. Nature 427: 461 
– 465. 
 50
z Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM and Chan DC. (2004) 
Structural basis of mitochondrial tethering by mitofusin complexes. Science. 
305(5685):858-62. 
z Kowaltowski A.J., Castilho R.F. and Vercesi A.E.(2001) Mitochondrial 
permeability transition and oxidative stress. FEBS Lett. 495:12–15. 
z Kowaltowski AJ, Vercesi AE and Fiskum G. (2000) Bcl-2 prevents 
mitochondrial permeability transition and cytochrome c release via 
maintenance of reduced pyridine nucleotides. Cell Death Differ. 
7(10):903-910. 
z Krauskopf A., Eriksson O., Craigen W.J., Forte M.A. and Bernardi P.(2006) 
Properties of the permeability transition in VDAC1(−/−) mitochondria. 
Biochim. Biophys. Acta 1757: 590–595. 
z Kroemer, G and Reed, JC (2000). Mitochondrial control of cell death. Nat Med 
6(5): 513-519. 
z Lapidus RG and Sokolove PM (1994) The mitochondrial permeability 
transition. Interactions of spermine, ADP, and inorganic phosphate. J. Biol. 
Chem. 269:18931-18936. 
z Le Quôc K and Le Quôc D (1985) Crucial role of sulfhydryl groups in the 
mitochondrial inner membrane structure. J Biol Chem 260: 7422 – 7428. 
z Le Quoc K.and Le Quoc D. (1988) Involvement of the ADP/ATP carrier in 
calcium-induced perturbations of the mitochondrial inner membrane 
 51
permeability: importance of the orientation of the nucleotide binding site. 
Arch. Biochem. Biophys. 265: 249–257. 
z Leducq N, Bono F, Sulpice T, Vin V, Janiak P, Fur GL, O'Connor SE and 
Herbert JM (2003) Role of peripheral benzodiazepine receptors in 
mitochondrial, cellular, and cardiac damage induced by oxidative stress and 
ischemia-reperfusion. J Pharmacol Exp Ther 306: 828 – 837. 
z Lee J, Jeong SY, Karbowski M, Smith CL and Youle RJ. (2004) Roles of the 
mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 
in apoptosis. Mol. Biol. Cell. 15: 5001-5011. 
z Lee MS, Kim JY and Park SY. (2004) Resistance of rho(0) cells against 
apoptosis. Ann N Y Acad Sci. 1011:146-153. 
z Legros F, Lombes A, Frachon P and Rojo M. (2002). Mitochondrial fusion in 
human cells is efficient, requires the inner membrane potential, and is 
mediated by mitofusins. Mol Biol Cell.13:4343-4354. 
z Lehninger AL, Vercesi A..and Bababunmi EA. (1978) Regulation of Ca2+ 
release from mitochondria by the oxidation-reduction state of pyridine 
nucleotides. Proc. Natl. Acad. Sci. USA 75 :1690–1694 
z Leu JI, Dumont P, Hafey M, Murphy ME and George DL. (2004) 
Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 
complex. Nat Cell Biol. 6(5): 443-450. 
z Li LY, Luo X and Wang X. (2001) Endonuclease G is an apoptotic DNase 
when released from mitochondria. Nature. 412(6842):95-99. 
 52
z Liu J, Farmer JDJ, Lane WS, Friedman J , Weissman I and Schreiber SL (1991) 
Calcineurin is a common target of cyclophilin-cyclosporin A and 
FKBP-FK506 complexes. Cell 66: 807 – 815. 
z Liu X., Kim C.N., Yang J, Jemmerson R. and Wang X. (1996) Induction of 
apoptotic program in cell-free extracts: requirement for dATP and cytochrome 
c. Cell 86:147–157. 
z Luo, X, Budihardjo, I, Zou, H, Slaughter, C and Wang, X (1998). Bid, a Bcl2 
interacting protein, mediates cytochrome c release from mitochondria in 
response to activation of cell surface death receptors. Cell 94(4): 481-490. 
z Lutter M, Fang M, Luo X, Nishijima M, Xie X and Wang X. (2000) 
Cardiolipin provides specificity for targeting of tBid to mitochondria. Nat 
Cell Biol. 2(10):754-761. 
z Majewski N,Nogueira V, Bhaskar P, Coy PE, Skeen JE, Gottlob K, Chandel NS, 
Thompson CB, Robey RB and Hay N. (2004) Hexokinase-mitochondria 
interaction mediated by Akt is required to inhibit apoptosis in the presence or 
absence of Bax and Bak. Mol Cell. 16(5):819-830. 
z Mannella CA, Marko M, Penczek P, Barnard D and Frank J. (1994) The 
internal compartmentation of rat-liver mitochondria: tomographic study using 
the high-voltage transmission electron microscope. Microsc Res Tech. 
27(4):278-283. 
z Mannella CA, Pfeiffer DR, Bradshaw PC, Moraru II, Slepchenko B, Loew LM, 
Hsieh CE, Buttle K and Marko M. (2001) Topology of the mitochondrial 
 53
inner membrane: dynamics and bioenergetic implications. IUBMB Life. 
52(3-5):93-100. 
z Marchetti P, Susin SA, Decaudin D, Gamen S, Castedo M, Hirsch T, Zamzami 
N, Naval J, Senik A and Kroemer G. (1996) Apoptosis-associated 
derangement of mitochondrial function in cells lacking mitochondrial DNA. 
Cancer Res. 56(9):2033-2038. 
z Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, 
Prevost MC, Xie Z, Matsuyama S, Reed JC and Kroemer G. (1998) Bax and 
adenine nucleotide translocator cooperate in the mitochondrial control of 
apoptosis. Science. 281(5385):2027-2031. 
z Mayer A, Neupert W and Lill R. (1995) Translocation of apocytochrome c 
across the outer membrane of mitochondria. J Biol Chem. 
270(21):12390-12397. 
z McEnery MW, Snowman AM, Trifiletti RR and Snyder SH (1992) Isolation of 
the mitochondrial benzodiazepine receptor: association with the 
voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl 
Acad Sci USA. 89: 3170 – 3174. 
z McGill A, Frank A, Emmett N, Turnbull DM, Birch-Machin MA and Reynolds 
NJ. (2005) The anti-psoriatic drug anthralin accumulates in keratinocyte 
mitochondria, dissipates mitochondrial membrane potential, and induces 
apoptosis through a pathway dependent on respiratory competent 
mitochondria. FASEB J. 19(8):1012-1014. 
 54
z McGuinness O., Yafei N., Costi A. and Crompton M. (1990) The presence of 
two classes of high-affinity cyclosporin A binding sites in mitochondria. 
Evidence that the minor component is involved in the opening of an 
inner-membrane Ca(2+)-dependent pore. Eur. J. Biochem. 194: 671–679. 
z Meier, P, Finch, A and Evan, G. (2000) Apoptosis in development. Nature 407: 
796-801. 
z Miramar MD, Costantini P, Ravagnan L, Saraiva LM, Haouzi D, Brothers G, 
Penninger JM, Peleato ML, Kroemer G and Susin SA. (2001) NADH oxidase 
activity of mitochondrial apoptosis-inducing factor. J Biol Chem. 276(19): 
16391-16398. 
z Moss M.L., Palmer R.E., Kuzmic P., Dunlap B.E., Henzel W., Kofron J.L., 
Mellon W.S., Royer C.A. and Rich D.H.(1992) Identification of actin and 
HSP 70 as cyclosporin A binding proteins by photoaffinity labeling and 
fluorescence displacement assays. J. Biol. Chem. 267: 22054–22059. 
z Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, 
Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL and Fesik SW. 
(1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of 
programmed cell death. Nature. 381(6580):335-341. 
z Mullauer, L, Gruber, P, Sebinger, D, Buch, J, Wohlfart, S and Chott, A. (2001) 
Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat 
Res 488(3): 211-31. 
 55
z Naismith, JH and Sprang, SR (1998). Modularity in the TNF-receptor family. 
Trends Biochem Sci 23(2): 74-9. 
z Nakagawa T , Shimizu S , Watanabe T , Yamaguchi O , Otsu K , Yamagata H , 
Inohara H , Kubo T and Tsujimoto Y (2005) Cyclophilin D-dependent 
mitochondrial permeability transition regulates some necrotic but not 
apoptotic cell death. Nature 434: 652 – 658. 
z Nakano K. and Vousden KH. (2001) PUMA, a novel pro-apoptotic gene, is 
induced by p53. Mol Cell. 7: 683–694. 
z Nicolli A, Basso E, Petronilli V, Wenger R.M. and Bernardi P. (1996) 
Interactions of Cyclophilin with the Mitochondrial Inner Membrane and 
Regulation of the Permeability Transition Pore, a Cyclosporin A-sensitive 
Channel. J. Biol. Chem. 271: 2185-2192. 
z Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H and Tsujimoto 
Y. (2003)  14-3-3 interacts directly with and negatively regulates 
pro-apoptotic Bax. J Biol Chem. 278: 2058-2065. 
z Oda E., Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, 
Taniguchi T and Tanaka N. (2000) Noxa, a BH3-only member of the Bcl-2 
family and candidate mediator of p53-induced apoptosis. Science 288: 
1053–1058. 
z O'Gorman E, Beutner G, Dolder M, Koretsky AP, Brdiczka D and Wallimann T. 
(1997) The role of creatine kinase in inhibition of mitochondrial permeability 
transition. FEBS Lett. 414(2):253-257. 
 56
z Orrenius S and Zhivotovskv B. (2005) Cardiolipin oxidation sets cytochrome c 
free. Nat. Chem. Biol. 1: 188-189. 
z Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, Hardwick 
M, Li H, Vidic B, Brown AS, Reversa JL, Bernassau JM and Drieu K.(1997) 
Peripheral benzodiazepine receptor in cholesterol transport and 
steroidogenesis. Steroids 62: 21 – 28. 
z Park SY, Chang I, Kim JY, Kang SW, Park SH, Singh K and Lee MS. (2004) 
Resistance of mitochondrial DNA-depleted cells against cell death: role of 
mitochondrial superoxide dismutase. J Biol Chem. 279(9):7512-7520. 
z Pastorino JG, Shulga N and Hoek JB.(2002) Mitochondrial binding of 
hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol 
Chem. 277(9):7610-7618. 
z Pastorino JG, Simbula G, Gilfor E, Hoek JB and Farber JL (1994) 
Protoporphyrin IX, an endogenous ligand of the peripheral benzodiazepine 
receptor, potentiates induction of the mitochondrial permeability transition 
and the killing of cultured hepatocytes by rotenone. J Biol Chem 269: 31041 
– 31046. 
z Petit P.X., Goubern M., Diolez P., Susin S.A., Zamzami N. and Kroemer G. 
(1998) Disruption of the outer mitochondrial membrane as a result of large 
amplitude swelling: the impact of irreversible permeability transition. FEBS 
Lett. 426:111–116. 
 57
z Petronilli V, Costantini P, Scorrano L, Colonna R, Passamonti S and Bernardi P. 
(1994) The voltage sensor of the mitochondrial permeability transition pore is 
tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating 
potential by oxidants and its reversal by reducing agents. J Biol Chem. 269: 
16638-16642. 
z Petronilli V, Penzo D, Scorrano L, Bernardi P and Di Lisa F (2001) The 
mitochondrial permeability transition, release of cytochrome c and cell death. 
Correlation with the duration of pore openings in situ . J Biol Chem 276: 
12030 – 12034 . 
z Puthalakath H, Huang DC, O'Reilly L A, King SM and Strasser A. (1999) The 
pro-apoptotic activity of the Bcl-2 family member Bim is regulated by 
interaction with the dynein motor complex. Mol Cell. 3: 287-296. 
z Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, 
Huang DC and Strasser A. (2001)  Bmf: a pro-apoptotic BH3-only protein 
regulated by interaction with the myosin V actin motor complex, activated by 
anoikis. Science 293: 1829-1832. 
z Reed JC. (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1(2): 
111-121. 
z Reed, JC (1998). Bcl-2 family proteins. Oncogene 17(25): 3225-3236. 
z Robey RB and Hay N. (2006) Mitochondrial hexokinases, novel mediators of 
the antiapoptotic effects of growth factors and Akt. Oncogene. 
25(34):4683-4696. 
 58
z Saito M, Korsmeyer SJ and Schlesinger PH. (2000) BAX-dependent transport 
of cytochrome c reconstituted in pure liposomes. Nat Cell Biol. 2(8):553-555. 
z Saraste A, Pulkki K.  (2000) Morphologic and biochemical hallmarks of 
apoptosis. Cardiovasc Res. 45(3):528-537 
z Satoh M, Hamamoto T, Seo N, Kagawa Y and Endo H. (2003) Differential 
sublocalization of the dynamin-related protein OPA1 isoforms in 
mitochondria. Biochem Biophys Res Commun. 300(2):482-493. 
z Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S. 
(2003) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. 
Nat Cell Biol. 5(4):320-329. 
z Scaffidi, C, Fulda, S, Srinivasan, A, Friesen, C, Li, F, Tomaselli, KJ, Debatin, 
KM, Krammer, PH and Peter, ME (1998). Two CD95 (APO-1/Fas) signaling 
pathways. Embo J 17(6): 1675-1687. 
z Schlattner U, Dolder M, Wallimann T and Tokarska-Schlattner M.(2001) 
Mitochondrial creatine kinase and mitochondrial outer membrane porin show 
a direct interaction that is modulated by calcium. J Biol Chem. 
276:48027-48030. 
z Schlattner U, Forstner M, Eder M, Stachowiak O, Fritz-Wolf K and Wallimann 
T. (1998) Functional aspects of the X-ray structure of mitochondrial creatine 
kinase: a molecular physiology approach. Mol Cell Biochem. 
184(1-2):125-140. 
 59
z Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA and 
Korsmeyer SJ. (2002) A distinct pathway remodels mitochondrial cristae and 
mobilizes cytochrome c during apoptosis. Dev Cell. 2(1): 55-67. 
z Scorrano L, Nicolli A, Basso E, Petronilli V and Bernardi P. (1997) Two modes 
of activation of the permeability transition pore: the role of mitochondrial 
cyclophilin. Mol Cell Biochem. 174(1-2):181-184. 
z Shimizu S, Konishi A, Kodama T and Tsujimoto Y. (2000) BH4 domain of 
antiapoptotic Bcl-2 family members closes voltage-dependent anion channel 
and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad 
Sci U S A. 97(7):3100-3105. 
z Shimizu S, Narita M and Tsujimoto Y. (1999) Bcl-2 family proteins regulate 
the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. 
Nature. 399(6735):483-487. 
z Sorgato MC, Keller BU and Stühmer W (1987) Patch-clamping of the inner 
mitochondrial membrane reveals a voltage-dependent ion channel . Nature 
330: 498 – 500. 
z Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, 
Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, 
Aebersold R, Siderovski DP, Penninger JM and Kroemer G. (1999) Molecular 
characterization of mitochondrial apoptosis-inducing factor. Nature. 
397(6718):441-446. 
 60
z Suzuki M, Jeong SY, Karbowski M, Youle RJ and Tjandra N. (2003) The 
solution structure of human mitochondria fission protein Fis1 reveals a novel 
TPR-like helix bundle. J Mol Biol. 334(3):445-458. 
z Szabó I, De Pinto V and Zoratti M. (1993) The mitochondrial permeability 
transition pore may comprise VDAC molecules. II. The electrophysiological 
properties of VDAC are compatible with those of the mitochondrial 
megachannel. FEBS Lett 330: 206 – 210. 
z Tanveer A., Virji S., Andreeva A., Totty N., Hsuan J.J., Ward J.M.and 
Crompton M. (1996)  Involvement of cyclophilin D in the activation of a 
mitochondrial pore by Ca2+ and oxidant stress. Eur. J. Biochem. 
238:166–172. 
z Tittel JN, Steller H. (2000) A comparison of programmed cell death between 
species. Genome Biol. 1(3):REVIEWS0003 
z Vercesi A.E., Kowaltowski A.J, Grijalba M.T., Meinicke A.R. and Castilho R.F. 
(1997) The role of reactive oxygen species in mitochondrial permeability 
transition. Biosci. Rep. 17:43–52. 
z Vinogradov A , Scarpa A and Chance B (1972) Calcium and pyridine 
nucleotide interaction in mitochondrial membranes. Arch Biochem Biophys 
152: 646 – 654. 
z von Ahsen O, Renken C, Perkins G, Kluck RM, Bossy-Wetzel E and 
Newmeyer DD.(2000) Preservation of mitochondrial structure and function 
 61
after Bid- or Bax-mediated cytochrome c release. J Cell Biol. 
150(5):1027-1036. 
z Walter L, Nogueira V, Leverve X, Heitz MP, Bernardi P and Fontaine E. (2000) 
J Biol Chem. 275: 29521-29527. 
z Wang H , Pathan N , Ethell IM , Krajewski S , Yamaguchi Y , Shibasaki F , 
McKeon F , Bobo T , Franke TF and Reed JC (1999) Ca2+-induced apoptosis 
through calcineurin dephosphorylation of BAD. Science 284: 339 – 343. 
z Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, 
McKeon F, Bobo T, Franke TF, Reed JC. (1999) Ca2+-induced apoptosis 
through calcineurin dephosphorylation of BAD. Science 284: 339–343. 
z Wang JL, Liu D, Zhang ZJ, Shan S, Han X, Srinivasula SM, Croce CM, 
Alnemri ES and Huang Z.(2000) Structure-based discovery of an organic 
compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. 
Natl. Acad. Sci. USA. 97:7124–7129. 
z Wang X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 
15(22):2922-2933. 
z Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB 
and Korsmeyer SJ. (2000) tBID, a membrane-targeted death ligand, 
oligomerizes BAK to release cytochrome c. Genes Dev. 14: 2060–2071. 
z Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, 
Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ. (2001) 
 62
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial 
Dysfunction and Death. Science. 292: 727-730. 
z Weiler, U, Riesinger, I, Knoll, G and Brdiczka, D. (1985) The regulation of 
mitochondrial-bound hexokinases in the liver. Biochem Med. 33: 223-235. 
z Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG and Youle RJ. (1997) 
Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell 
Biol. 139(5):1281-1292. 
z Woodfield K., Ruck A., Brdiczka D. and A.P. Halestrap. (1998) Direct 
demonstration of a specific interaction between cyclophilin-D and the adenine 
nucleotide translocase confirms their role in the mitochondrial permeability 
transition. Biochem. J. 336: 287–290. 
z Yang QH, Church-Hajduk R, Ren J, Newton ML and Du C. (2003) Omi/HtrA2 
catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs 
and facilitates caspase activity in apoptosis. Genes Dev. 17(12):1487-1896. 
z Zamzami N and Kroemer G. (2001) The mitochondrion in apoptosis: how 
Pandora's box opens. Nature Rev. Mol. Cell Biol. 2: 67-71. 
z Zha J, Harada H, Yang E, Jockel J and Korsmeyer SJ. (1996)  Serine 
phosphorylation of death agonist BAD in response to survival factor results in 
binding to 14-3-3 not Bcl-xL. Cell. 87: 619-628. 
z Zha J, Weiler S, Oh KJ, Wei MC and Korsmeyer SJ. (2000) Posttranslational 
N-myristoylation of BID as a molecular switch for targeting mitochondria and 
apoptosis. Science. 290(5497):1761-1765. 
 63
z Zizi M, Forte M, Blachly-Dyson E, Colombini M. (1994) NADH regulates the 
gating of VDAC, the mitochondrial outer membrane channel. J Biol Chem. 
269(3):1614-1616. 
z Zoratti M. and Szabo I. (1995) The mitochondrial permeability transition. 
Biochim. Biophys. Acta 1241:139–176. 
z Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali 
EL, Zappia M, Nelis E, Patitucci A, Senderek J, Parman Y, Evgrafov O, 
Jonghe PD, Takahashi Y, Tsuji S, Pericak-Vance MA, Quattrone A, Battaloglu 
E, Polyakov AV, Timmerman V, Schroder JM and Vance JM. (2004) 
Mutations in the mitochondrial GTPase mitofusin 2 cause   





















Chapter 2  
Materials and Methods 
Materials and cell culture 
THG was obtained from Molecular Probes (Eugene, Oregon, USA). Ru360 was 
purchased from Calbiochem (San Diego, CA). Fluorescent probes including 
tetra-methyl rhodamine methyl ester (TMRM), Fluo3-AM, Rhod2-AM, 
MitoTracker green, propidium iodide (PI), 4’, 6-diamidino-2-phenylindole, 
dihydrochloride (DAPI) Dichlorofluorescein (DCFDA) and dihydroethidium 
(DHE) were from Molecular Probes (Eugene, Oregon, USA). zVADfmk and 
DEVDfmk caspase inhibitors, STS, CsA and BAPTA-AM were purchased from 
Sigma Chemical Company.(St. Louis, MO, USA). Leukemic CEM cells were 
cultured in RPMI-1640 media and passaged daily to maintain them in log-phase 
growth and kept at a nominal concentration of 2.5- 5 x 105/ ml. Cell viability 
studies were performed by trypan blue exclusion method. CEM ρ0 cells were 
derived from CEM ρ+ cells in the presence of 50 ng/ml ethidium bromide to 
inhibit mitochondrial DNA replication for more than 20 generations until use. 
CEM ρ0 was determined by nonitoring cells for KCN-sensitive oxygen 
consumption and COX II subunit protein expression by western blot until oxygen 
consumption and COX II expression were 90% reduced. CEM ρ0 cells were 
maintained in RPMI-1640 media in the presence of 110 μg/ml pyruvate and 50 
μg/ml uridine.  
Apoptosis determination 
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THG was used at a concentration of 1 μM and STS was used at a concentration of 
500 nM unless otherwise stated. Cellular apoptosis was determined by performing 
FACS cell cycle analysis of PI (20 μg/ml) stained CEM cells. The percentage of 
cells in the subG1 zone was taken to indicate the percentage of cells undergoing 
apoptosis. DAPI (3 μM) staining was also monitored by fluorescence microscopy 
to visually estimate cells containing fragmented DNA.   
Caspase- 3 activity assays 
EnzChek®Caspase-3 Assay kits were purchased from Molecular probes (Eugene, 
Oregon, USA). CEM cell caspase-3 activity was determined using a caspase-3 
synthetic fluorescent substrate. Assays were performed according to the 
manufactures instructions. Substrate cleavage increases fluorescence which was 
measured using Molecular Probes fluorometer model # GEMINI XS (excitation 
@ 342 nm and emission @ 441 nm). 
FACS analysis for cytosolic and mitochondrial Ca2+ levels  
Cytosolic Ca2+ levels were determined using the fluorescent dye Fluo-3AM (1μM) 
(log mode in FITC setting). Mitochondrial Ca2+ levels were determined using the 
fluorescent dye Rhod-2 AM (250 nM) (log mode PE setting). Cells (parental, 
cyclophilin D (Cyp-D) knockdown and Bax knockdown) were treated with THG ± 
Ru360 (10 μM) or CsA (1 μM)  for the times indicated and incubated with 
fluoresecent dyes for 15 min at 37°C, and washed with PBS containing 10 mM 
glucose and analyzed immediately by flow cytometry. In each analysis, 10,000 
events were recorded.  
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Laser scanning confocal microscopy 
CEM cells were loaded with 1 μM Rhod2-AM in buffer containing 100 mM KCl, 
10 mM MOPS pH=7.2 for 60 min. After loading with Rhod2-AM, cells were 
transferred to primary culture for an additional 18 hr to eliminate the residual 
cytosolic fraction of the Rhod2 dye. To determine the mitochondrial localization 
of the Rho2 probe, cells were simultaneously loaded with 100 nM MitoTracker 
green (a mitochondria-selective dye which is concentrated by active mitochondria) 
and 300 nM DAPI in primary culture medium for 60 min.  Fluorescence images 
of Rhod 2 were acquired using 552 nm excitation and 581 nm emission; 
fluorescence images of  MitoTracker green were acquired using 490 nm 
excitation and 516 nm emission and DAPI using 358 nm excitation and 461 nm 
emission.  
FACS analysis for determination of Δψm  
Cells after corresponding treatments were loaded with 250 nM TMRM (TMRM is 
a cationic dye which accumulates within mitochondria in accordance with the 
Δψm  Nernest potential) for 15 min and red fluorescence was determined by 
FACS analysis using PE setting. The protonophore carbonyl CCCP (10 μM) was 
used to dissipate the chemiosmotic proton gradient (⊿μH+) and served as a 
control for loss ofΔψm. Representative results shown as two dimensional color 
density plots of TMRM stained cells showing percentage number of cells with 
intact Δψm (TMRM fluorescence in top right quadrant). For semi-quantitative 
determination of ∆ψm, TMRM (40 nM) fluorescence was monitored in parental 
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CEM ρ+ cells and CEM ρ0 cells before and after treatment with the detergent 
NP40 using a modified Nernst equation: Δψm = -60mV x log [TMRM 
fluorescence of control] / [TMRM fluorescence intensity of NP40 treatment] 
(Esposti, 2001). Δψm of ρ0 cells was determined to be approximately 20mV lower 
(~ 110 mV) compared to ρ+ cells (~130 mV).In each analysis, 10,000 events were 
recorded. 
Determination of oxidation (ROS) production  
Two dyes were applied to detect oxidation production. DCFDA is used for general 
oxidative stress and DHE is specific for free radical production. Cells after proper 
treatment were loaded with 10 μM DCFDA for 15 min and washed with PBS 
containing 10 mM glucose and analyzed immediately by FACS using FITC 
channel (log mode). In each analysis, 10,000 events were recorded. Cells after 
proper treatment were loaded with 10 μM DHE for 15 min and washed with PBS 
containing 10 mM glucose and analyzed immediately by FACS using PE-Texas 
Red channel (log mode). In each analysis, 10,000 events were recorded.  
Transmission electron microscopy (TEM)  
CEM cells in the logarithmic proliferation phase, were treated with THG (1 μM) ± 
the inhibitors as described in figure legends. Cells were fixed with 2.5% 
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 at room temperature for 1 h and 
washed with 0.1 M cacodylate buffer and post-fixed with 1% osmium tetraoxide 
in 0.1 M cacodylate buffer and dehydrated with graded series of ethanol, and 
embedded in LX112. Thin sections were prepared, and stained with uranyl acetate. 
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Specimens were examined on a JEOL 1000X electron microscope operating at 80 
KV. 
Subcellular Fractionation  
Subcellular fractionation was performed as described previously with the 
following modifications. Following treatment, cells (~1 x 107) were harvested by 
centrifugation (600g for 10 min at 4°C). Cell pellets were washed with ice-cold 
PBS and suspended in HEPES buffer at pH 7.4   Cells were disrupted using a 
27½ gauge needle and the cell homogenate was centrifuged at 800g for 10 min at 
4°C to remove nuclei and unbroken cells. The supernatant from this preparation 
was centrifuged at 10,000 x g for 10 min and the pellet was designated the  
‘mitochondrial’ fraction while the supernatant was centrifuged at 100,000 x g for 
60 min at 4°C and the resulting supernatant was used for preparation of cytosolic 
fraction. The mitochondrial and cytosolic fractions were stored at -80°C until 
experimentation. Protein assay was performed by Dc protein assay (Bio-Rad, 
Hercules CA). 
Mitochondrial Isolation, Swelling Test and detection of 
cytochrome c release 
Rat liver mitochondria (RLM) were isolated by conventional differential 
centrifugation from the livers of male adult Sprague-Dawley rats fasted overnight. 
The isolation buffer consists of mannitol (220 mM), sucrose (70 mM), Hepes (2 
mM), EGTA (0.5 mM), and bovine serum albumin (0.1%), pH 7.4. Isolated RLM 
were suspended in storage buffer consisting of 200mM sucrose and 2mM HEPES, 
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pH 7.4. Large amplitude swelling was measured by spectrophotometry in a 
Beckman DU 640 by recording absorbance change at 540 nm in incubation buffer 
consisting of 200 mM sucrose, 20 µM EGTA, 5 mM succinate, 2 µM rotenone, 1 
µg/ml oligomycin, 20 mM Tris, 20 mM HEPES, and 1 mM KH2PO4, pH 7.2. To 
measure cytochrome c release from RLM induced by different additions, RLM 
(0.5 mg/ml) in storage buffer were incubated with Ca2+ (625 μM) ±CsA (50 μM) 
or DIG (100 pmol/mg protein) for 10 min, then the incubated RLM were 
centrifuged at 10,000 x g for 10 min at 4°C. The supernatant fractions were further 
spun at 100,000 x g for 15 min at 4°C to eliminate mitochondrial membrane 
fragments and the resulting supernatants were used to determine cytochrome c 
released from RLM. 
Mitochondrial oxygen consumption 
Oxygen consumption was measured with a Clark oxygen electrode (Oxygraph 
Model 5300: Yellow Spring Instrument Co., Yellow Spring, OH). Oxygen 
consumption was monitored in 150 mM sucrose, 5 mM MgCl2, 5 mM succinate, 1 
µM, rotenone, and 10 mM NaPi buffer, pH 7.4.Mitochondria’s respiratory control 
ratios (RCR) were calculated after addition of 200 µM ADP . 
Immunoblotting  
Proteins were separated by electrophoresis on 14% SDS-PAGE gels and 
transferred to nitrocellulose membrane. Protein concentration was determined 
using Bio-Rad Dc protein assay. Rabbit polyclonal anti-Bax (N20) antibody was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA) while rabbit 
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polyclonal anti-Cyp-D antibody was from Calbiochem (San Diego, CA). 
Bip/Grp78 was detected by rabbit polyclonal antibody (Stressgen biotechnologies); 
CHOP/GADD153 was detected by rabbit polyclonal antibody (Santa Cruz 
biotechnology, Santa Cruz, CA). Mouse monoclonal anti-OPA1, anti-cytochrome 
c, anti-β actin and anti-MnSOD antibodies were from BD Biosciences, 
Pharmingen (San Diego, CA). COX II was detected by mouse monoclonal 
antibody (Molecular probes. Eugene, Oregon, USA). The secondary antibodies 
used were goat anti-rabbit and goat anti-mouse horseradish peroxidase-conjugated 
antibodies, respectively, and they were purchased from BD Biosciences, 
Pharmingen (San Diego, CA). Chemiluminescence detection was performed using 
ECL detection kit according to the manufactures instructions (Pierce, USA).  
Bax and Cyclophilin D (Cyp-D) gene silencing with small 
interfering RNAs (siRNAs)  
Gene silencing with small interfering RNAs (siRNAs) (sense and antisense 
strands) were purchased from 1st BASE, Britain. The sense strand sequences were: 
control, 5’-UUCUCCGAACGUGUCACGU(dTdT)-3’; Bax, 
5’-GGUGCCGGAACUGAUCAGA(dTdT)-3’ and Cyp-D, 
5’-CCUGCUAAAUUGUGCGUUA(dTdT)-3’. Cells were transfected with 
siRNAs using lipofectamine 2000 (Invitrogen, CA, USA) according to the 
manufacturer’s instructions for 48 h unless otherwise stated. Following 




Data were expressed as standard error of the mean (SE) of 3 or more separate 









































Bax and the mitochondrial permeability transition 
cooperate in the release of cytochrome c during 
endoplasmic reticulum stress induced apoptosis 
(Adapted from: Zhang D and Armstrong JS. (2007) Cell Death Differ. 
14:703-715.) 
 
Endoplasmic reticulum (ER)-stress induces apoptosis by mechanisms that are not 
fully clear. Here we show that ER-stress induced by the Ca(2+)-ATPase inhibitor 
thapsigargin (THG) activates cytochrome c-dependent apoptosis through 
cooperation between Bax and the mitochondrial permeability transition (MPT) in 
human leukemic CEM cells.  Pharmacological inhibition of the MPT as well as 
interference RNA knockdown of the MPT core component cyclophilin D (Cyp-D) 
blocked cytochrome c release and caspase-dependent apoptosis but did not 
prevent Bax activation, translocation or N-terminal exposure in mitochondria.  
Interference RNA knockdown of Bax also blocked THG-mediated cytochrome c 
release and apoptosis, but did not prevent MPT activation and converted 
caspase-dependent cell death to caspase independent cell death. Our results show 
that ER-stress induced cell death involves a caspase and Bax-dependent pathway 




The endoplasmic reticulum (ER) regulates protein synthesis and intracellular 
calcium (Ca2+) homeostasis (Xu et al, 2005; Rutkowski and Kaufman, 2004; 
Boyce and Yuan, 2006). Excessive ER stress can trigger apoptosis through a 
variety of mechanisms including redox imbalance, alterations in Ca2+ levels and 
activation of Bcl-2 family proteins (Furuya et al, 1994; McCullough et al, 2001; 
Yamaguchi et al, 2003; Yamaguchi and Wang, 2004) . Thapsigargin (THG) is a 
sesquiterpenoid plant alkaloid frequently used to study the molecular mechanisms 
regulating ER-stress induced apoptosis and has previously been found to induce 
apoptosis in cancer cell lines via activation of the death receptor pathway and the 
mitochondrial pathway (Yamaguchi et al, 2003; Yamaguchi and Wang, 2004). The 
mitochondrial apoptotic signalling pathway has previously been shown to involve 
activation of the multidomain pro-apoptotic Bcl-2 family members including Bax 
that induce permeabilization of the outer mitochondrial membrane and release of 
cytochrome c (Roucou et al, 2002; Korsmeyer et al, 2000). Although, the 
mechanism(s) leading to Bax activation and translocation to mitochondria are 
incompletely understood, its integration into the mitochondrial outer membrane 
appears to depend on a conformational change which exposes the N-terminus of 
the protein on the membrane surface, while its C-terminus facilitates membrane 
insertion (Scorrano et al, 2003; Goping et al, 1998). In the outer membrane, Bax is 
thought to undergo oligomerization to form a pore or channel that facilitates the 
release of cytochrome c (Roucou et al, 2002; Nechushtan et al, 1999; 
Jürgensmeier et al, 1998; Antonsson et al, 2000; Mikhailov et al, 2001). However, 
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in addition to Bax, it is clear that other key events are required to cause the 
complete release of cytochrome c from mitochondria including disruption of the 
electrostatic interactions of cytochrome c with mitochondrial membrane lipids to 
facilitate its release from other components of the electron transport chain (ETC) 
(Iverson and Orrenius, 2004; Orrenius and Zhivotovsky, 2005) structural changes 
to the mitochondrial cristae inner-membrane (Scorrano et al, 2002; Kim et al, 
2004) and the activation of the mitochondrial permeability transition (MPT) 
( Yang and Cortopassi, 1998; Bradham et al, 1998).  
  The role of the MPT in the release of cytochrome c and induction of apoptosis 
has recently been challenged by the observation that cells, isolated from 
genetically modified mice, lacking the MPT core component cyclophilin D 
(Cyp-D) were not protected from Bcl-2 family member regulated cell death 
indicating that the MPT does not play a major role in apoptosis (Nakagawa et al, 
2005; Baines et al, 2005). However, this idea contrasts previous reports showing 
that Bcl-2 family proteins, including Bax, interact with components of the MPT 
including the adenine nucleotide translocator (ANT) and the voltage-dependent 
anion channel (VDAC) to regulate apoptosis (Reed et al, 1998; Brenner et al, 
2000; Vieira et al, 2000; Narita et al, 1998; Zamzami et al , 2000; Marzo et al, 
1998; Shimizu et al, 1999; Shimizu et al, 2000). These controversies prompted us 
to investigate the role of the MPT and Bax in ER-stress induced apoptosis. 
  In this study, we used interference RNA technology to investigate the role of the 
MPT and Bax in apoptosis induced by ER stress. Our results suggest that, in 
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addition to Bax, calcium-dependent mitochondrial changes, including activation 
of the MPT, are crucial for the successful release of cytochrome c and induction of 





3.2.1 THG treatment induces cytosolic and mitochondrial 
Ca2+ increase in CEM cells 
Figure 3.1A shows results of an immunoblot of Cyp-D protein expression in 
CEM cells after transfection with control siRNA (left) and Cyp-D siRNA (right). 
Cells transfected with Cyp-D siRNA showed a significant decrease (estimated at ~ 
90%) in expression of Cyp-D protein levels compared to cells transfected with 
control siRNA. Figure 3.1B, left captions show representative FACS analysis 
histograms of Fluo3-AM stained CEM cells before and after treatment with either 
THG ± ruthenium 360 (Ru360), cyclosporin A (CsA) or after siRNA knockdown 
of Cyp-D. The thin black trace shows FACS results of the control; the heavy black 
trace shows FACS results after THG treatment and the heavy green trace shows 
results after treatment with (a) THG + Ru360, (b) THG + Cyp-D siRNA treatment 
and (c) THG + CsA. The figure shows a representative example of three 
independent experiments. In each analysis, 10,000 events were recorded. Figure 
3.1B, left caption (d) shows a bar graph of cytosolic calcium levels expressed as 
mean Fluo3 fluorescence intensity normalized to control.  The data are expressed 
as means ± S.E. (n = 3) Figure 3.1B, Right captions show representative FACS 
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analysis histograms of Rhod2-AM stained CEM cells as described above for 
Fluo3-AM. The thin black trace shows FACS results of the control; the heavy 
black trace shows results after THG treatment and the heavy green trace shows 
results after treatment with (a) THG + Ru360, (b) THG + Cyp-D siRNA treatment 
and (c) THG + CsA. The figure shows a representative example of three 
independent experiments. In each analysis, 10,000 events were recorded. Figure 
1B, right caption d) shows a bar graph of mitochondrial calcium levels expressed 
as mean Rhod2 fluorescence intensity normalized to control. The data are 
expressed as means ± S.E. (n = 3). Results show that THG significantly increased 
Fluo3 fluorescence in CEM cells which was not altered by treatment with Ru360 
(to block mitochondrial calcium uptake) or either by MPT inhibition with CsA or 
siRNA Cyp-D knockdown. Results show that THG significantly increased Rhod2 
fluorescence in CEM cells which was effectively blocked by treatment with 
Ru360, but not by MPT inhibition with CsA or by siRNA Cyp-D knockdown.  
Figure 3.1C, shows representative confocal images of CEM cells loaded with 
DAPI, MitoTracker green and Rhod2 after treatment with THG or THG +Ru360. 
Merge shows that THG increased Rhod 2 fluorescence in mitochondria of CEM 















Figure 3.1A: Results of an immunoblot of Cyp-D protein expression in CEM cells 
after transfection with control siRNA (left) and Cyp-D siRNA (right) performed 























































































































































Figure 3.1B: Cytosolic calcium panel: representative FACS analysis histograms 
of Fluo3-AM stained CEM cells treated with THG ± (a) Ru360, (b) Cyp-D siRNA 
and (c) CsA. Thin black trace: control; heavy black trace: THG; heavy green trace: 
THG + respective treatment. Panel (d) shows bar graph of cytosolic calcium 
levels (mean ± S.E) expressed as mean Fluo3 fluorescence intensity normalized to 
control. The cells were loaded with 1 μM Fluo3-AM for 15 min and the green 
fluorescence was immediately measured by flow cytometry using the FITC setting 
as described under "Materials and Methods".  In each analysis, 10,000 events 
were recorded. Mitochondrial calcium panel: representative FACS analysis 
histograms of Rhod2-AM stained CEM cells treated with THG ± (a) Ru360, (b) 
Cyp-D siRNA and (c) CsA. Thin black trace: control; heavy black trace: THG; 
heavy green trace: THG + respective treatment. Panel (d) shows bar graph of 
mitochondrial calcium levels (mean ± S.E) expressed as mean Rhod2 fluorescence 
intensity normalized to control. The cells were loaded with 250 nM Rhod 2-AM 
for 15 min and the red fluorescence was immediately measured by flow cytometry 
using the PE setting as described under "Materials and Methods" In each analysis, 









Figure 3.1C: shows representative confocal images of CEM cells loaded with 
DAPI, MitoTracker green and Rhod2-AM after treatment with THG or THG 









3.2.2 THG causes loss of mitochondrial membrane 
potential (Δψm): evidence of Ca2+ induced MPT  
  Δψm was determined in CEM cells, after treatment with THG, by monitoring the 
fluorescence of the cationic potentiometric dye TMRM performed as described in 
the materials and methods section. Figure 3.2 shows representative two 
dimensional colour density plots of TMRM stained cells showing percentage 
number of cells with intact Δψm (TMRM fluorescence in top right quadrant) 
versus percentage number of cells with reduced Δψm (TMRM fluorescence in 
bottom left quadrant). Figure shows TMRM fluorescence of cells treated for 36 h 
with (a) RPMI (control), (b) THG , (c) THG + Ru360, (d) THG + siRNA Cyp-D 
and (e) THG + CsA. The figure shows a representative example of three 
independent experiments. In each analysis, 10,000 events were recorded. Figure 
3.2, (f) shows the percentage (mean ± S.E.) of CEM cells with intact Δψm at 0, 12, 
24 and 36 h after treatment with THG as described above. At 36 h, TMRM 
fluorescence was observed in (a) 93% control cells, (b) 8 % in cells treated with 
THG, (c) 53 % in cells treated with THG + Ru360, (d) 59% in cells treated with 
THG after siRNA Cyp-D knockdown and (e) 68 % of cells treated with  THG + 
CsA. Results in panel (f) show that THG treatment caused a time-dependent loss 
of TMRM fluorescence over 36 h which was significantly blocked by Ru360, CsA 




















































Figure 3.2 Representative TMRM fluorescence two dimensional colour density 
plots showing percentage number of cells with intact Δψm (TMRM fluorescence in 
top right quadrant) and  percentage number of cells with reduced Δψm (TMRM 
fluorescence in bottom left quadrant) 36 h after treatment with THG. (a) RPMI 
(control), (b) THG, (c) THG + Ru360, (d) THG + siRNA CyD, (e) THG + CsA. 
The cells were loaded with 250 nM TMRM for 15 min and the red fluorescence 
was immediately measured by flow cytometry using the PE setting as described 
under "Materials and Methods". In each analysis, 10,000 events were recorded. 
Panel (f) shows a graph of the percentage (mean ± S.E.) of CEM cells with intact 







3.2.3 THG induces mitochondrial cytochrome c release, 
caspase-3 cleavage and DNA fragmentation of CEM cells 
Figure 3.3A shows representative results of cytochrome c immunoblots of CEM 
cells co-incubated with THG ± Ru360 (Top panel),  THG ± CsA (Bottom panel) 
or treated with Cyp-D siRNA for 48 h then THG (Middle panel) for 36 h 
determined as described in the materials and methods section. β actin was used as 
a loading control. Results show that THG induced a time-dependent increase in 
cytosolic cytochrome c band which was significantly reduced by Cyp-D siRNA 
knockdown or by treatment with Ru360 or CsA. Figure 3.3B shows a bar graph of 
caspase-3 activity determined as described in the materials and methods section. 
Figure shows mean caspase-3 activity 36 h after treatment with THG ± Ru360; 
CsA or Cyp-D siRNA. Results show that blocking mitochondrial Ca2+ increase or 
MPT activation with CsA or by siRNA Cyp-D knockdown inhibited 
THG-mediated caspase-3 processing. Figure 3.3C shows representative cell cycle 
analysis FACS histograms of propidium iodide (PI) stained CEM cells after 
treatment with (a) RPMI (control), (b) THG, (c) THG + Ru360, (d) THG after 
pre-treatment with Cyp-D siRNA and (e) THG + CsA for 36 h. Inset figures 
shows results of 4'-6-Diamidino-2-phenylindole (DAPI) staining of cells shown in 
corresponding FACS histograms. Results show that inhibition of mitochondrial 











Figure 3.3A, Top panel shows representative cytochrome c immunoblot  
determined on the cytosolic fractions of CEM cells before and after treatment with 
THG ± Ru360 for 0, 12, 24 and 36 h. β actin was used as a loading control. 
Middle panel shows representative cytochrome c immunoblot determined on the 
cytosolic fractions of CEM cells after treatment with THG for 0, 12, 24 and 36 h 
before and after Cyp-D siRNA knockdown. β actin was used as a loading control. 
Bottom panel shows representative cytochrome c immunoblot determined on the 
cytosolic fractions of CEM cells before and after treatment with THG ± CsA for 0, 




























































Figure 3.3B, Figure shows bar graph of caspase-3 activity (mean ± S.E.) before 
and after treatment with THG ± Ru360; THG ± CsA or THG before and after 













Figure 3.3 C Representative cell cycle analysis FACS histograms of PI stained 
CEM cells after treatment with (a) RPMI (control), (b) THG, (c) THG + Ru360, 
(d) THG after pre-treatment with Cyp-D siRNA and (e) THG + CsA for 36 h. 
Percentage cells containing hypodiploid amount of DNA (subG1 fraction) 
indicated. Inset figures shows results of DAPI staining of cells shown in 






3.2.4 CsA blocks THG-induced cell death in siRNA Cyp-D 
knockdown cells  
Although, CsA is known to block the MPT in isolated mitochondria and in 
mitochondria in situ, it is also known to have a variety of non-specific effects on 
cells that could contribute to its effects on mitochondrial cytochrome c release and 
activation of apoptosis. To investigate whether CsA was non-specifically blocking 
THG-induced cell death we treated CEM parental cell and cells pre-treated with 
Cyp-D siRNA for 48 h with THG in the presence and absence of CsA. Figure 
3.4A, cell viability assay (trypan blue exclusion) shows that CsA blocked 
THG-induced loss of cell viability in CEM parental cells as well as in siRNA 
Cyp-D knockdown cells. Figure 3.4B shows electron micrographs of the 
mitochondrial ultrastructure of CEM cells after treatment with (a) RPMI control, 
(b) THG and (c) THG + CsA for 36 h. Results show that CsA preserved the 
ultrastructure of the mitochondrial cristae (indicated by arrow heads). These 
results indicated that the THG-induced mitochondrial Ca2+-dependent changes 
contributing to the release of cytochrome c from mitochondria included the MPT 





































Figure 3.4 A, Parental CEM cells and Cyp-D knockdown cells were treated with 
THG ± CsA and cell viability was determined by trypan blue exclusion at 0, 12, 






























Figure 3.4 B Mitochondrial ultrastructure of CEM cell mitochondria determined 
by TEM before and after treatment with THG ± CsA for 36 h. (a) RPMI control, 


















3.2.5 Bax translocation and N-terminal exposure is 
independent of MPT  
Since Bax is known to regulate cytochrome c release and cell death, we next 
investigated the role of Bax in THG induced cell death. Figure 3.5A shows 
representative Bax (N20 antibody) immunoblots performed on the mitochondrial 
fractions taken from CEM cells determined as described in the methods section. 
CEM cells were treated with (Top panel) THG ± Ru360, (Middle panel) THG ± 
siRNA CyD pre-treatment for 48 h or (Bottom panel) THG ± CsA for 24 h. 
Manganese superoxide dismutase (MnSOD) was used as a loading control. 
Results show that THG induced a time-dependent increase in mitochondrial Bax 
which was not significantly reduced by siRNA Cyp-D knockdown or by Ru360 or 
CsA. These results indicated that Bax activation and translocation to mitochondria 
was independent of the MPT. To determine the role of cytosolic Ca2+ in Bax 
activation and translocation to mitochondria we treated CEM cells with THG in 
the presence and absence of the Ca2+ chelating agent BAPTA-AM. Figure 3.5B 
(part a) shows representative FACS analysis histograms of Fluo3-AM stained 
CEM cells before and after treatment with THG in the presence and absence of 
BAPTA-AM. Thin black trace shows control cells; heavy black trace shows cells 
after treatment with THG and heavy green trace shows cells after treatment with 
THG + BAPTA-AM. The figure shows a representative example of three 
independent experiments. In each analysis, 10,000 events were recorded. Figure 
3.5B, (part b) shows a bar graph of cytosolic calcium levels ± BAPTA-AM 
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expressed as mean Fluo3 fluorescence intensity normalized to control.  The data 
are expressed as means ± S.E. (n = 3). The results show that the Ca2+ chelating 
agent BAPTA-AM blocked cytosolic Ca2+ increase. Figure 3.5B, (part c) shows 
representative Bax (N20 antibody) immunoblot of CEM mitochondrial fractions 
after treatment of cells with THG ± BAPTA-AM for 24 h. Results show that THG 
induced time-dependent increase in mitochondrial Bax which was not 
significantly reduced by co-incubation with BAPTA-AM. These results indicated 
that Bax activation and translocation to mitochondria was independent of 






































Figure 3.5 A, Top panel shows representative Bax (N20 antibody) immunoblot 
determined on the mitochondrial fractions of CEM cells before and after treatment 
with THG ± Ru360 for 0, 6, 12 and 24 h. MnSOD was used as a loading control. 
Middle panel shows representative Bax (N20 antibody) immunoblot determined 
on the mitochondrial fractions of CEM cells treated with THG for 0, 6, 12 and 24 
h before and after pre-treatment with Cyp-D siRNA. MnSOD was used as a 
loading control. Bottom panel shows representative Bax (N20 antibody) 
immunoblot determined on the mitochondrial fractions of CEM cells before and 
after treatment with THG ± CsA for 0, 6, 12 and 24 h. MnSOD was used as a 









Figure 3.5 B, (a) representative FACS analysis histograms of Fluo3-AM stained 
CEM cells after treatment with THG ± BAPTA-AM. Thin black trace shows 
control cells; heavy black trace shows cells after treatment with THG and heavy 
green trace shows cells after treatment with THG + BAPTA-AM. (b) Bar graph 
showing cytosolic calcium levels in the presence and absence of BAPTA-AM 
expressed as mean Fluo3 fluorescence intensity normalized to control.  The data 
are expressed as means ± S.E. (n = 3). (c) shows representative Bax (N20 
antibody) immunoblot determined on the mitochondrial fractions of CEM cells 
before and after treatment with BAPTA-AM for 0, 6, 12 and 24 h. MnSOD was 
used as a loading control.  
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3.2.6 siRNA knockdown of Bax blocks THG induced 
release of cytochrome c and converts caspase-dependent 
cell death to caspase-independent cell death.  
Figure 3.6A, shows results of an immunoblot of Bax (N-20 antibody) protein 
expression performed on CEM cells after transfection with either control siRNA 
or Bax siRNA for 48 h. Cells transfected with Bax siRNA showed a significant 
decrease in expression of Bax protein (estimated at ~ 90 %) levels compared to 
cells transfected with control siRNA. Figure 3.6B shows (a) representative FACS 
analysis histogram of Fluo3-AM stained CEM cells before and after siRNA Bax 
knockdown in the presence and absence of THG. Black trace: parental control 
cells ± THG; green trace: siRNA Bax ± THG. (b) bar graph of cytosolic calcium 
levels in CEM cells after treatment with THG before and after siRNA Bax 
knockdown (mean ± S.E) expressed as mean Fluo3 fluorescence intensity 
normalized to control. (c) representative FACS analysis histograms of Rhod2-AM 
stained CEM cells before and after siRNA Bax knockdown in the presence and 
absence of THG ± Ru360. Black trace: parental control cells, parental control cells 
+ THG and parental control cells + THG + Ru360; green trace: siRNA Bax 
control,  siRNA Bax + THG and siRNA Bax + THG + Ru360. (d) bar graph of 
mitochondrial calcium levels in CEM cells before and after siRNA Bax 
knockdown in the presence and absence of THG or THG + Ru360 (mean ± S.E) 
expressed as mean Rhod2 fluorescence intensity normalized to control. Figure 
3.6C shows a representative cytochrome c immunoblot determined on cytosolic 
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fractions taken from CEM parental cells and CEM siRNA Bax knockdown cells 
after treatment with THG every 12 h for a total of 36 h. β actin was used as a 
loading control. Results show that THG induced time-dependent increase in 
cytosolic cytochrome c protein band which was blocked by siRNA Bax 
knockdown. Figure 3.6D, Δψm was determined in parental cells treated with THG 
± zVADfmk and siRNA Bax knockdown cells treated with THG ± zVADfmk or 
CsA by monitoring TMRM fluorescence as described for figure 2. Figure shows 
TMRM fluorescence of cells treated with (a) THG at 0, 24 and 48 h (b) THG + 
zVADfmk at 0, 24 and 48 h (c) THG + siRNA Bax at 0, 24 and 48 h (d) THG + 
siRNA Bax + zVADfmk at 0, 24 and 48 h and (e) THG + siRNA Bax + CsA at 0, 
24 and 48 h. The figure shows a representative example of three independent 
experiments. In each analysis, 10,000 events were recorded. Panel a shows THG 
treatment for 48 h caused loss of TMRM fluorescence in 90 % of cell population 
compared to 36 % in cells treated with zVADfmk as showed in panel b. Panel c 
shows THG treatment for 48 h in siRNA Bax knockdown cells caused loss of 
TMRM fluorescence in ~ 56 % of cell population compared to ~ 62 % in cells 
treated with zVADfmk as showed in panel d. Panel e shows that THG treatment 
for 48 h in siRNA Bax knockdown cells treated with CsA caused loss of TMRM 
fluorescence in ~ 30% of cell population. Results show that THG-mediated loss of 
Δψm in parental cells was inhibited by caspase inhibition (Δψm preserved in ~ 54 
% of cells with zVADfmk). THG-mediated loss of Δψm in siRNA Bax knockdown 
cells was not inhibited by caspase inhibition (Δψm not preserved with zVADfmk), 
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but was protected by CsA (Δψm preserved in ~ 65 % of cells with CsA).  Figure 
3.6D, (f) shows the percentage (mean ± S.E.) of CEM cells with intact Δψm after 
treatment with THG as described for figure 2. Figure 3.6E shows results of a cell 
viability assay of THG treated CEM parental cells and siRNA Bax knockdown 
cells in the presence and absence of zVADfmk. Results show that zVADfmk 
blocked loss of cell viability induced by THG in parental cells, but not in siRNA 
Bax knockdown cells. Figure 3.6F shows representative FACS analysis cell cycle 
histograms of PI stained THG-treated CEM parental cells and siRNA Bax 
knockdown cells monitored at 0, 24, 48, 72 and 96 h. Results show that THG 
treatment induced a significant increase in the subG1 fraction of parental CEM 
cells but not in siRNA Bax knockdown CEM cells. Figure 3.6G shows a bar graph 
of caspase-3 activity determined as described for figure 3.3B. Figure shows mean 
caspase-3 activity 12, 24, 36 and 48 h after treatment of parental cells and siRNA 
Bax knockdown cells with THG. Results show that siRNA Bax knockdown 
inhibited THG-mediated caspase-3 processing. Together, these results indicated 



































Figure 3.6A, Results of an immunoblot of Bax (N-20 antibody) protein 
expression performed on CEM cells after transfection with either control siRNA 























































































































































Figure 3.6B, (a) representative FACS analysis histogram of Fluo3-AM stained 
CEM cells before and after siRNA Bax knockdown in the presence and absence of 
THG. Black trace: parental control cells ± THG; green trace: siRNA Bax ± THG. 
(b) bar graph of cytosolic calcium levels in CEM cells after treatment with THG 
before and after siRNA Bax knockdown (mean ± S.E) expressed as mean Fluo3 
fluorescence intensity normalized to control. (c) representative FACS analysis 
histograms of Rhod2-AM stained CEM cells before and after siRNA Bax 
knockdown in the presence and absence of THG ± Ru360. Black trace: parental 
control cells, parental control cells + THG and parental control cells + THG + 
Ru360; green trace: siRNA Bax control,  siRNA Bax + THG and siRNA Bax + 
THG + Ru360. (d) bar graph of mitochondrial calcium levels in CEM cells before 
and after siRNA Bax knockdown in the presence and absence of THG or THG + 















Figure 3.6C, representative cytochrome c immunoblot determined on the 
cytosolic fractions of CEM cells treated with THG for 0, 12, 24 and 36 h before 


























Figure 3.6D, Representative TMRM fluorescence two dimensional colour density 
plots showing percentage number of cells with intact Δψm and percentage number 
of cells with reduced Δψm before and after treatment with THG for 48 h (as 
described in figure 2). (a) Parental CEM cells + THG, (b) Parental CEM cells + 
THG + zVADfmk, (c) siRNA Bax knockdown CEM cells + THG, (d) siRNA Bax 
knockdown CEM cells + THG + zVADfmk, (e) siRNA Bax knockdown CEM 
cells + THG + CsA. The cells were loaded with 250 nM TMRM for 15 min and 
the red fluorescence was immediately measured by flow cytometry using the PE 
setting as described under "Materials and Methods" In each analysis, 10,000 
events were recorded. Inset figure (f) shows a graph of the percentage (mean ± 
S.E.) of CEM parental and siRNA Bax knockdown cells with intact Δψm 

















Figure 3.6E,Graph showing viability of CEM parental and siRNA Bax 
knockdown cells after treatment with THG ± zVADfmk and siRNA Bax 

































Figure 3.6F, Representative FACS analysis cell cycle histograms of PI stained 
CEM parental and siRNA Bax knockdown CEM cells after treatment with THG 
for 0, 24, 48, 72 and 96 h. Percentage cells containing hypodiploid amount of 





























Figure 3.6G, Bar graph of caspase-3 activity after treatment of CEM parental and 










3.2.7 Contribution of the MPT to the release of 
cytochrome c from mitochondria 
During ER stress-induced apoptosis we observed that Bax was necessary but not 
sufficient for complete cytochrome c release from mitochondria. We, therefore, 
considered that the MPT was involved in the mobilization of cytochrome c from 
mitochondria and Bax provided a cytochrome c access channel to the cytosol. To 
investigate the role of the MPT in the release of cytochrome c release we treated 
isolated rat liver mitochondria (RLM) with either Ca2+ to induce the MPT or 
Ca2++ CsA to block the MPT and determined the relative release of cytochrome c 
into the mitochondrial suspension buffer by Western blot. To investigate the role 
of Bax as a pore forming protein in the mitochondrial outer membrane we 
determined the proportion of cytochrome c in the mitochondrial inter-membrane 
space by removing the mitochondrial outer membrane of RLM with digitonin 
(DIG) and determining cytochrome c release into the mitochondrial suspension 
buffer by western blot. Figure 3.7A shows a representative example of 
Ca2+-induced swelling profile of RLM in the presence and absence of CsA 
showing that CsA blocks large amplitude swelling indicative of the MPT. Figure 
3.7B top panel shows oxygen consumption and calculated respiratory control 
ratios (RCR) of RLM suspensions (a) before and (b) after treatment with DIG; 
middle panel shows representative results of an immunoblot for cytochrome c 
performed on aliquots of mitochondrial suspension buffer (a) after treatment with 
Ca2+ ± CsA and (b) after treatment with either Ca2+ or DIG (see materials and 
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methods); bottom panel shows bar graph of relative cytochrome c band density 
determined from the immunoblots shown in ‘middle panel’ measured by scanning 
densitometry. Results show that the major fraction of cytochrome c is released 
upon MPT activation and a minor fraction is released by removing the 
mitochondrial outer membrane. In conjunction with our in situ data these results 
suggest that the Bax-mediated permeabilization of the outer mitochondrial 
membrane provides the critical access point for cytochrome c release to the 
cytosol during ER-stress induced apoptosis but requires the MPT and non-MPT 
mediated structural changes to cristae for complete release of cytochrome c and 
activation of apoptosis. However, this is not to say that Bax only mediates outer 
membrane permeabilization since it may also be involved in facilitating 

































Figure 3.7A, figure shows representative example of Ca2+-induced swelling 
profile of RLM in the presence and absence of CsA.  RLM (0.5mg protein/ml) 
were treated with 200 μM Ca2+ ± CsA and absorbance at 540 nm was monitored 




















 Figure 3.7B, Top  panel. (a) Oxygen consumption of isolated RLM with 
estimated RCR ~ 6.9, (b) oxygen consumption of RLM after treatment with DIG 
with estimated RCR ~ 3.7. Middle panel (a) representative cytochrome c 
immunoblot determined on the supernatant fractions taken from RLM suspensions 
treated with Ca2+ ± CsA. (b) representative cytochrome c immunoblot determined 
on the supernatant fractions taken from RLM suspensions treated with Ca2+ or 
DIG. Bottom panel shows bar graph of cytochrome c band density determined 




























Figure 3.8 Hypothetical model showing key events regulating ER-stress induced 
apoptosis in human leukemic CEM cells. The Ca2+-induced MPT and structural 
changes to the mitochondrial cristae and possibly CJ are responsible for the 
release of the major fraction of cytochrome c from the ETC to activate apoptosis. 
Bax forms a simple pore or channel in the mitochondrial outer membrane to 
facilitate the release of cytochrome c into the cytosol. In the model we show that 
Bax and the MPT are independent events activated by ER stress, but cooperate to 
bring about the complete release of cytochrome c from mitochondria leading to 
caspase 3-dependent apoptosis. 
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3.3 DISCUSSION    
In this study, we investigated mitochondrial events regulating ER-stress 
induced apoptosis in human leukemic CEM cells using the drug THG. Three 
independent lines of evidence showed a key role for increased mitochondrial Ca2+ 
in THG-mediated cytochrome c release and induction of apoptosis. First, 
pharmacological inhibition of mitochondrial Ca2+ increase (using Ru360 to block 
uniporter function) prevented cytochrome c release and apoptosis. Second, CsA, 
the classical MPT inhibitor, also effectively prevented cytochrome c release and 
apoptosis and third interference RNA knockdown of Cyp-D, a key regulatory 
component of the MPT, also prevented cytochrome c release and apoptosis. These 
results clearly indicated the requirement of increased mitochondrial Ca2+ levels 
and MPT activation for the induction of CEM cell death. However, since CsA is 
relatively non-specific in its action, we also considered that, in addition to its 
effects on the MPT, CsA might be inhibiting apoptosis via an additional 
mechanism (Crabtree, 2001; Fruman et al; 1992; Moss et al, 1992; Epand et al, 
2002; Lucken-Ardjomande and Martinou, 2005). To determine the role of CsA in 
the regulation of THG-induced apoptosis we treated siRNA Cyp-D knockdown 
cells with THG in the presence and absence of CsA (Figure 3.4). We found that 
CsA protected Cyp-D knockdown cells from THG-induced loss of viability which 
indicated that in addition to its known effects on the MPT, CsA was protecting 
CEM cells against ER stress induced apoptosis by an additional mechanism. The 
nature of the MPT-independent protective mechanism(s) is unclear, although, 
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transmission electron microscopy (TEM) results clearly showed that CsA partly 
preserved the mitochondrial ultrastructure of the cristae suggesting a structural 
role for the effects of CsA. This result is in agreement with the previous findings 
of Scorrano et al., 2002 and Kim and colleagues, 2004 who showed that Bid 
induced mitochondrial cytochrome c release required structural remodelling of the 
mitochondrial cristae and contact junctions (CJ) between the mitochondrial outer 
and inner membranes (Scorrano et al, 2002; Kim et al, 2004).  
THG-induced ER-stress also caused the robust activation, translocation and 
N-terminal exposure of Bax in the mitochondria of CEM cells. The mechanism 
involved is currently unknown, but may depend on activation of the death receptor 
pathway via CHOP, DR5 and caspase-8 as previously reported (Yamaguchi and 
Wang, 2004) since we found that Bax translocation to mitochondria was not 
dependent on ER-stress induced Ca2+ increase (Figure 3.5B, part c). The role of 
Bax in THG-induced apoptosis in CEM cells was investigated using interference 
RNA to knockdown Bax protein expression. siRNA knockdown of Bax 
completely prevented THG-induced cytochrome c release and partially inhibited 
apoptosis indicating that Bax was required for the induction of cytochrome 
c-dependent apoptosis. However, because activation and translocation of Bax to 
mitochondria occurred unimpaired by Ru360, or by blocking the MPT with either 
CsA, or by Cyp-D knockdown, indicated that only Bax was insufficient for 
successful induction of apoptosis during ER stress. These results indicated that 
Bax and the MPT were independent signals that cooperated during ER stress 
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induced apoptosis in CEM cells. Our results are, however, in contrast a recent 
report that showed that the MPT signalled the activation and translocation of Bax 
to mitochondria during TMRM induced photoexcitation (De Giorgi et al, 2002). 
Although, the reason for this discrepancy is not known, TMRM photoexitation 
might also cause ER-stress in addition to MPT activation which would be 
expected to recruit the involvement of Bax. Alternatively, since the MPT can be 
either CsA-regulated or CsA-unregulated (He and Lemasters, 2002; Kowaltowski 
et al, 2001; Armstrong and Jones, 2002; Armstrong et al, 2004). The 
TMRM-induced photoexitation MPT model might be the result of excessive redox 
stress which has previously been found to activate Bax (Jungas et al, 2002; Liu et 
al, 2005; Simon et al, 2000). 
To investigate the relative contribution of Bax and the MPT to cytochrome c 
release in CEM cells we noted that after MPT inhibition a minor fraction of 
cytochrome c (estimated at between 15-20 %) was still detected by immunoblot. 
We considered that this minor fraction, which was insufficient to activate 
apoptosis, might represent the cytochrome c residing in the mitochondrial 
inter-membrane space and not functioning in electron transport. To investigate this, 
we considered that we should be able to measure a similar quantity of cytochrome 
c released from the inter-membrane space of isolated RLM after removing the 
mitochondrial outer membrane, and if this fraction of cytochrome c was not 
involved in electron transport then the mitochondria would remain coupled. 
Figure 3.6B shows that after treatment with the detergent DIG to remove the outer 
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mitochondrial membrane, RLM released approximately ~15-20 % of their total 
complement of cytochrome c into the mitochondrial suspension buffer, but still 
remained significantly coupled (although RCR fell from 6.9 to 3.7). These studies 
provided evidence, although indirect, that during ER-stress induced apoptosis the 
MPT was responsible for the release of a major fraction of cytochrome c derived 
from the mitochondrial ETC. Since we also found that CsA blocked the release of 
approximately 80-85 % of cytochrome c from isolated RLM treated with Ca2+ to 
induce the MPT (figure 3.7B (a) middle panel) this also supported the notion that 
the MPT was responsible for the release of the major fraction of cytochrome c 
from RLM. These results support the idea that Bax forms a simple channel 
allowing cytochrome c release into the cytosol as previously reported (Ott et al, 
2002), and indicate that the MPT as well as structural changes occurring in the 
mitochondrial cristae, are essential for the complete release of cytochrome c 
during ER stress-induced apoptosis (this idea is shown in Figure 3.8).  
In conclusion, our results show that ER stress-induced apoptosis requires 
cooperation between Bax and Ca2+-dependent mitochondrial modifications 
including the MPT and CsA-sensitive structural changes to mitochondrial cristae. 
The result of this cooperation is a coordinated mechanism that regulates the 
complete release of mitochondrial cytochrome c and activation of the 
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Mitochondrial permeability transition regulates cristae 
junction remodeling and cytochrome c release during 
endoplasmic reticulum stress-induced apoptosis 
(Adapted from: Zhang D et al. (2008) J. Biol. Chem. 283: 3476-3486.) 
The role of the mitochondrial permeability transition (MPT) in apoptosis and 
necrosis is controversial. Here we show, using isolated mitochondria and leukemic 
CEM cells, that the MPT induces mitochondrial structural remodeling of the 
cristae junction (CJ) to facilitate mitochondrial release of cytochrome c for 
apoptosis. Leukemic CEM cells were treated with the endoplamic reticulum (ER) 
stressor thapsigargin (THG) which led to cyclophilin-D (Cyp-D) regulated release 
of the mitochondrial pro-fusion GTPase OPA1 protein, which controls CJ integrity, 
and cytochrome c inducing caspase 3-dependent apoptosis. Interference RNA 
knockdown of Bax prevented OPA1 and cytochrome c release, but it did not 
prevent the MPT indicating that Bax was essential for MPT-dependent release of 
cytochrome c. In isolated mitochondria, MPT also led to OPA1 and cytochrome c 
release and this occurred independently of the VDAC. Lastly, the MPT and 
cytochrome c release was regulated by the electron transport chain (ETC), but not 
mitochondrial reactive oxygen species (ROS), since THG did not induce death in 
cells lacking mtDNA and death was not blocked in parental cells by antioxidant 
treatment. Our results show that ER stress induces the MPT which controls the 
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release of cytochrome c for apoptosis by releasing OPA1 protein from the CJ and 
that the MPT is required for Bax to execute the apoptotic program. 
4.1 Introduction 
  The endoplasmic reticulum (ER) regulates protein synthesis and intracellular 
calcium (Ca2+) homeostasis (Xu et al, 2005). Excessive ER stress triggers 
apoptosis through a variety of mechanisms including activation of the unfolded 
protein response (UPR), alterations in Ca2+ levels and activation of Bcl-2 family 
proteins (Xu et al, 2005; Rutkowski and Kaufman, 2004; Boyce and Yuan, 2006). 
The SERCA-ATPase inhibitor thapsigargin (THG) has been used to study ER 
stress-induced apoptosis implicating Bax (Yamaguchi et al, 2003; Yamaguchi and 
Wang, 2004), the UPR (Yamaguchi and Wang, 2004) and the mitochondrial 
permeability transition (MPT) (Zhang and Armstrong, 2007) as key factors 
involved. However, the relationship between these events and the mechanism 
regulating apoptosis by the MPT remains unclear.  
      The role of the MPT in cell death is controversial due, in part, to current 
lack of knowledge of its molecular structure and its regulation (Bernardi et al, 
2006; Armstrong 2006). For example, although recent genetic studies with 
cyclophilin D (Cyp-D) knockout mice have shown that the MPT primarily 
regulates necrosis and not apoptosis (Nakagawa et al, 2005; Baines et al, 2005), 
many earlier studies showed that Bax interacted with components of the MPT, 
including VDAC (Pastorino et al, 2002) and ANT (Marzo et al, 1998), to regulate 
apoptosis and we recently showed that Bax and the MPT regulated the 
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mitochondrial release of cytochrome c for apoptosis (Zhang and Armstrong, 
2007). Mechanistically, early studies suggested that the MPT caused cytochrome 
c release by inducing non-specific mitochondrial swelling and organelle rupture 
(Petit et al, 1996; Green and Reed,1998; Skulachev 2000; Jiang et al, 2001). 
However, in contrast to this idea, other reports have shown that cytochrome c can 
be released from mitochondria without significant swelling or outer membrane 
rupture (Gao et al, 2001; Gogvadze et al, 2004). Recently it has been shown that 
the mitochondrial cytochrome c release mechanism is highly regulated and 
involves a number of discrete steps (Ott et al, 2002; Scorrano et al, 2002) 
including structural remodeling of the mitochondrial cristae junctions (CJ) and 
outer membrane permeabilization (Scorrano et al, 2002). The MPT was 
implicated in remodeling of the CJ because it was blocked by the MPT inhibitor 
cyclosporine A (CsA) (Scorrano et al, 2002); however, the relationship between 
CJ remodeling and the MPT is currently unknown.  
    Here we show, using isolated mitochondria and leukemic CEM cells, that the 
MPT induces mitochondrial structural remodeling of the cristae membrane, by 
releasing OPA1 from the CJ, to facilitate mitochondrial release of cytochrome c 
for apoptosis. In cells, the MPT failed to release cytochrome c from mitochondria 
in the absence of Bax indicating that the MPT does not rupture the organelle’s 
outer membrane for cytochrome c release. While in isolated mitochondria, the 
MPT caused OPA1 and cytochrome c release independently of the mitochondrial 
outer membrane and the putative component VDAC. Lastly, we show that the 
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MPT is dependent on a functional electron transport chain (ETC) but does not 
depend on mitochondrial ROS production and therefore is not redox-regulated. 
 
4.2 Results 
4.2.1 MPT activation induces the co-release of OPA1 and 
cytochrome c from isolated mitochondria and from 
mitochondria in situ 
An initial aim for this study was to determine the relationship between the MPT, 
changes in the structure of the CJ and the release of cytochrome c from 
mitochondria. Since structural remodeling of the CJ is accompanied by the release 
of the OPA1 protein (Frezza et al, 2006) which allows the complete release of 
cytochrome c from mitochondria (Arnoult et al, 2005) we determined the release 
of OPA1 and cytochrome c from RLM in response to the MPT. Figure 4.1A shows 
a representative example of Ca2+-induced mitochondrial swelling profile of RLM. 
Mitochondrial swelling was inhibited by MPT inhibitors CsA, bongkrekic acid 
(BGK) and Ru360. The amount of OPA1 and cytochrome c released into the 
incubation buffer after MPT was determined. Results indicated that both proteins 
were co-released from mitochondria in a MPT dependent manner since their 
release was blocked by CsA, BGK and Ru360; inhibitors of the MPT (Figure 
4.1B). We next determined whether the MPT in cells would cause the co-release 
of both OPA1 and cytochrome c. CEM cells were treated with THG ± CsA, BGK 
and Ru360 and mitochondrial Ca2+ levels, Δψm (as an indicator of MPT activation) 
and cytosolic OPA1 and cytochrome c were determined. THG treatment increased 
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mitochondrial Ca2+ levels (blocked by Ru360, but not CsA or BGK), reduced the 
percentage numbers of cells displaying Δψm and caused loss of mitochondrial 
cristae structure blocked by MPT inhibitors (Figure 4.1C). THG treatment also 
caused OPA1 and cyochrome c release CEM mitochondria blocked by MPT 
inhibitors (Figure 4.1D). Overall, these results indicated that the Ca2+-induced 
MPT caused co-release of OPA1 and cytochrome c from isolated mitochondria 
and mitochondria in situ suggesting that the MPT controls remodeling of the CJ 









































Figure 4.1 A Mitochondria (1 mg/ml protein) were incubated in MHS buffer 
±CsA (1 μM), BGK (10 μM) or Ru360 (10 μM for 2 min as described under 
Materials and Ca2+ was added (at point indicated by arrow). Mitochondrial 
swelling was monitored continuously at 540 nm. Representative swelling curves 






















Figure 4.1 B At the end of the incubation period samples were centrifuged, and 
the resulting supernatants separated by SDS- PAGE and Western-blotted for OPA1 




























Figure 4.1 C CEM cells were treated with 1 μM THG ± CsA (1 μM), BGK (10 
μM) or Ru360 (10 μM) for 36 h. Mitochondrial Ca2+ levels were measured by 
FACS analysis of Rhod2-AM stained cells as described in Materials and Methods 
(left captions). Δψm was determined by FACS analysis of TMRM stained cells as 
described in Materials and Methods and results are shown as color enhanced 
density plots: values shown indicate percentage cells with intact Δψm (middle 
captions) Mitochondrial cristae ultrastructure was determined in situ using TEM 
as described in Materials and Methods; arrow heads point to mitochondria with 










Figure 4.1 D CEM cells were treated with 1 μM THG ± CsA (1 μM), BGK (10 
μM) or Ru360 (10 μM) for times indicated and cytosolic fractions were harvested, 
separated by SDS-PAGE electrophoresis and Western immunoblotted for OPA1 
and cyochrome c as described in Materials and Methods. 
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4.2.2 Cyp-D regulates the release of OPA1 and 
cytochrome c during THG-dependent apoptosis 
Since pharmacological inhibitors are non-specific, small interference RNA 
(siRNA) was used to knockdown the MPT component Cyp-D to confirm the role 
of the MPT in the release of OPA1 and cytochrome c from mitochondria induced 
by THG. Staurosporine (STS) was used as a control since genetic studies have 
demonstrated that STS-induced apoptosis is not Cyp-D regulated (Nakagawa et al, 
2005; Baines et al, 2005). siRNA effectively reduced Cyp-D expression ~90% 
compared to scramble control siRNA or untreated cells (Figure 4.2A) and blocked 
the mitochondrial release of OPA1 and cytochrome c in response to THG (Figure 
2B); however, as expected, Cyp-D knockdown did not block OPA1 and 
cyctochrome c release in response to STS (Figure 4.2C). Δψm and mitochondrial 
cristae ultrastructure were determined in parental CEM and siRNA Cyp-D 
knockdown cells before and after treatment with THG and STS. Cyp-D 
knockdown blocked loss of Δψm and mitochondrial cristae ultrastructure after 
treatment with THG but not STS (Figures 4.2D and 4.2E). Cyp-D knockdown also 
prevented caspase-3 processing and the increase in fraction of apoptotic cells after 
THG treatment, but not STS treatment (Figure 4.2F). Since OPA1 regulates the 
structure of the CJ (Frezza et al, 2006) our results indicated that Cyp-D transduced 
the Ca2+ death signal by controlling CJ integrity (Schneider, 2005). These results 
are in agreement with the notion that the MPT regulates the structural 
re-organization of mitochondria in response to Ca2+ challenge and mitochondrial 
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Figure 4.2 A CEM cells were treated with either incubation media, control 
scramble siRNA or siRNA Cyp-D for 48h and cell lysates were separated by 






























Figure 4.2 B Parental CEM cells and siRNA knockdown cells were treated with 
THG for the times indicated and OPA1 and cytochrome c were determined as 
































Figure 4.2 C Parental CEM cells and siRNA knockdown cells were treated with 
STS for the times indicated and OPA1 and cytochrome c were determined as 





























Figure 4.2 D Δψm was determined in CEM parental and Cyp-D knockdown cells 























Figure 4.2 E TEM was determined in CEM parental and Cyp-D knockdown cells 



























Figure 4.2 F CEM parental and siRNA Cyp-D knockdown cells were treated with 
THG for 36 h or STS for 12 h and caspase 3 activity was determined (left) and for 











4.2.3 The MPT and Bax are required for the release of 
OPA1 and cytochrome c from mitochondria 
The mechanism of cytochrome c release from mitochondria by the MPT has been 
suggested to involve matrix swelling and organelle rupture (Petit et al, 1996; 
Green and Reed,1998; Skulachev 2000; Jiang et al, 2001). However, Bax is also 
known to play a role in apoptosis by providing a channel for the release of 
cytochrome c from mitochondria to the cytosol (Antignani and Youle, 2006) and 
we have recently shown that both Bax and the MPT are involved in the regulation 
of ER stress-induced apoptosis (Zhang and Armstrong, 2007). Therefore, to 
determine whether the MPT was sufficient for cytochrome c release, as predicted 
by the matrix swelling model, we silenced Bax expression and then induced the 
MPT by treating siRNA Bax knockdown CEM cells with THG. Bax siRNA 
effectively reduced Bax expression ~90% compared to scramble control siRNA or 
untreated cells (Figure 4.3A). In Bax knockdown cells, THG treatment caused 
CsA-sensitive loss of Δψm and loss of normal mitochondrial cristae ultrastructure 
indicating that THG treatment induced the MPT in siRNA Bax knockdown cells 
(Figure 4.3B). However, after Bax knockdown, THG treatment did not release 
mitochondrial OPA1 and cytochrome c compared to parental CEM cells(Figure 
4.3C)indicating that the MPT did not induce mitochondrial rupture and 
cytochrome c release but required Bax for this function. Furthermore, our results 
showed that the MPT alone mediated the structural changes to the mitochondrial 
cristae inner membrane in the absence of Bax (Figure 4.3B; center panel EM) 
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suggesting the release mechanism involves two discrete steps including 1) 
activation of a Bcl-2 pro-apoptotic protein, in this case Bax (Ott et al, 2002; 
Scorrano et al, 2002), and 2) structural remodeling of mitochondrial cristae 























Figure 4.3 A CEM cells were treated with either incubation media, control 
scramble siRNA or siRNA Bax for 48h and cell lysates were separated by 


























Figure 4.3 B Δψm and mitochondrial ultrastructure was determined in CEM 
parental and siRNA Bax knockdown cells before and after treatment with THG ± 





























Figure 4.3 C Parental CEM and siRNA Bax knockdown cells were treated with 
THG for times indicated and OPA1 and cytochrome c were determined as 














4.2.4 OPA1 and cytochrome c release from isolated 
mitochondria occurs independently of VDAC and the 
mitochondrial outer membrane.  
Since our model suggested that the MPT regulated the structure of the cristae and 
CJ (i.e., the mitochondrial inner membrane), we considered that outer membrane 
VDAC (Crompton et al, 1998) might not be a necessary component of the MPT. 
Mitochondria were first treated with proteinase K (prot. K), to remove the VDAC 
by digestion, and then treated with Ca2+ to induce MPT. Mitochondrial swelling 
profiles before and after prot. K treatment were monitored (Figure 4.4A). We 
observed no significant difference either between the mitochondrial swelling 
profiles or the quantity of OPA1 and cytochrome c released into the incubation 
buffer before or after prot. K treatment (Figures 4.4A and 4.4B). Mitochondria 
were next pre-incubated with digitonin (DIG), at concentrations previously found 
to remove the outer membrane (Scorrano et al, 2002; Zhang and Armstrong, 2007) 
and treated with Ca2+ to induce MPT. Mitochondrial swelling profiles before and 
after DIG treatment were monitored (Figure 4.4C). We observed no significant 
difference either between the mitochondrial swelling profiles or the quantity of 
OPA1 and cytochrome c released into the incubation buffer before or after DIG 
treatment (Figures 4.4C and 4.4E). The effects of DIG on the extent of 
mitochondrial coupling were determined by monitoring mitochondrial RCR as 
previously described (Scorrano et al, 2002; Zhang and Armstrong, 2007) and were 
not found to be significantly different before or after DIG treatment at the 
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concentration of DIG used (100 pmol/mg protein) (RCR before DIG treatment = 
6.2 compared to 5.6 after DIG treatment) (Figure 4.4D). Overall, the results 
indicated that the major fraction of cytochrome c is stored in mitochondrial cristae 
together with other ETC components as previously found (Ott et al, 2002; 
Scorrano et al, 2002) and showed that the MPT regulates the release of 
cytochrome c from mitochondria independently of the VDAC in agreement with 
recent genetic evidence (Baines et al, 2007) and the mitochondrial outer 




































Figure 4.4 A Mitochondria were incubated with 10 mg/ml prot K on ice for 10 
min as described in reference 41. PMSF (10 mM) was added to stop prot K 
digestion. Mitochondria were repelleted by centrifugation and treated with 200 
μM Ca2+. Mitochondrial swelling profile was monitored before and after prot K 
treatment as described in Materials and Methods. Representative swelling curves 
induced by untreated control mitochondria (trace 1), untreated control 
mitochondria incubated with prot K (trace 2), mitochondria incubated with prot. K 
and treated with 200 μM Ca2+ (trace 3) and mitochondria treated with 200 μM 















Figure 4.4 B OPA1 and cytochrome c released by the MPT into incubation 
medium before and after prot K digestion were determined. VDAC was 
determined in mitochondrial pellets before and after prot K treatment for control 




















Figure 4.4 C Mitochondria were incubated with 100 pmol/mg protein DIG on ice 
for 10 min, repelleted by centrifugation, and treated with 200 μM Ca2+. 
Mitochondrial swelling profile was monitored before and after DIG treatment. 
Representative swelling curves induced by untreated control mitochondria (trace 
1), untreated control mitochondria incubated with DIG (trace 2), mitochondria 
incubated with DIG and treated with 200 μM Ca2+ (trace 3) and mitochondria 































Figure 4.4 D RCR determined (state 4-state 3) oxygen consumption was 

























Figure 4.4 E After DIG treatment mitochondria were treated with 200 μM Ca2+ 
and OPA1, cytochrome c and VDAC released into incubation medium were 

























4.2.5 The ETC is indispensable for THG-induced MPT 
Two observations suggested a possible role for the ETC in MPT regulation. First, 
although previous reports have found that the mitochondrial ETC is dispensable 
for apoptosis (Jacobson et al, 1993; Jiang et al, 1999), both of these studies used 
STS to induce apoptosis, and STS-induced apoptosis is not regulated by the MPT 
(Nakagawa et al, 2005; Baines et al, 2005). Second, previous reports have found 
that the MPT is regulated by ETC complexes I and III (Fontaine and Bernardi, 
1999; Armstrong and Jones, 2002). To investigate the role of the ETC in 
THG-dependent cell death we created CEM cells lacking mtDNA (ρ0) as 
previously described (Chua et al, 2005). CEM cells were assigned ρ0 status when 
KCN-sensitive oxygen consumption was reduced ~90% (Figure 4.5G) and COX II 
expression was reduced by ~90% compared to parental (ρ+) cells (Figure 4.5A). ρ+ 
and ρ0 cells were treated with THG and Δψm, mitochondrial utrastructure and 
OPA1 and cytochrome c release were determined. Cells were also treated with 
STS for control purposes. ρ0 cells resisted loss of Δψm, loss of mitochondrial 
cristae ultrastructure compared to ρ+ cells in response to THG (Figures 4.5B and 
4.5D) and mitochondrial release of OPA1 and cytochrome c, caspase-3 processing 
and induction of apoptosis was significantly blocked compared to ρ+ cells (Figures 
4.5E and 4.5F). In contrast, ρ0 cells did not prevent STS-induced cell death when 
the same parameters were analyzed (Figures 4.5C, 4.5D, 4.5E and 4.5F). However, 
ρ0 cells showed a delayed release of cytochrome c compared to ρ+ cells (Figure 
4.5C) which may be the result of increased antioxidant defenses that ρ0 cells have 
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been previously shown to possess (Vergani et a., 2004; Park et al, 2004; Chua et 
al, 2005). When manganese superoxide dismutase (MnSOD) levels were 
determined in CEM ρ+ and ρ0 cells we found no significant difference in levels of 
MnSOD expression (data not shown) in contrast to the previous findings of Park 
and colleagues 2004. Taken together, the results show that THG, but not STS, 
induced apoptosis is regulated by the ETC and indicate that the ETC controls the 









































Figure 4.5 A CEM cells were treated with EtBr (50 ng/ml) as described in 
Materials and Methods. Cell lysates from ρ+ cells and ρ0 cells were separated by 



































Figure 4.5 B ρ+ and ρ0 cells were treated with THG for the times indicated and 

































Figure 4.5 C ρ+ and ρ0 cells were treated with STS for the times indicated and 


































Figure 4.5 D ρ+ and ρ0 cells were treated with THG for 36 h or STS for 9 h and 






















Figure 4.5E Caspase 3 activity was determined in ρ+ and ρ0 cells after treatment 































Figure 4.5 F Percentage subG1 fraction was determined in ρ+ and ρ0 cells after 
treatment with THG for 36 h or STS for 9 h as described in Fig. 2. Inset figures 
show representative ρ+ and ρ0 cells treated with THG or STS and stained with 
























Figure 4.5 G Top panel shows oxygen consumption was determined every week 
when creating ρ0 cells. Bottom panel shows representative oxygen consumption 
curve was shown after 4 weeks treatment of Ethdium bromide. As described in 
Materials and Methods. 
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4.2.6 Ca2+ signaling, Bax activation and induction of the 
UPR is conserved in CEM ρ0 cells  
Since the creation of ρ0 cells by long term treatment with ethidium Bromide (EtBr) 
(~ 4-6 weeks; Chua et al, 2005) induces a variety of biochemical changes (other 
than a dysfunctional ETC) which could account for their resistance to apoptosis, 
we compared ER-mitochondrial Ca2+ signaling, level of Bax activation and 
activation of the UPR response in both ρ+ and ρ0 cells. Three independent 
experiments showed that mitochondrial Ca2+ signaling in ρ0 cells was not 
significantly different to that in ρ+cells. THG-induced Rhod2 fluorescence was 
determined by Laser Scanning Confocal Microscopy (LSCM) in single cells and 
by spectrofluorimetry in cell populations. THG-dependent Rhod2 fluorescence 
increase was similar in magnitude in ρ+ and ρ0 cells and both signals were 
inhibited by Ru360 (Figures 4.6A and 4.6B). Rhod2 fluorescence was also 
determined by FACS analysis producing similar results (data not shown). Next we 
semi-quantitatively estimated the Δψm of ρ0 cells to determine whether the value 
obtained was consistent with electrophoretic uptake of Ca2+ since the Δψm of ρ0 
cells is known to be lower than in ρ+ cells (Appleby et al, 1999). Δψm of ρ0 cells 
was estimated to be approximately 20mV lower (~ 110 mV) compared to ρ+ cells 
(Figure 4.6C). This value is consistent with estimated Δψm values required to 
electrophoretically drive the Ca2+ uniporter (Crompton, 1999). Next, Bax 
activation and mitochondrial translocation were determined in both cell lines in 
response to THG treatment and were found not significantly different (Figure 
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4.6D). Finally, we investigated the UPR in ρ+ and ρ0 cells by monitoring 
Bip/Grp78 and CHOP expression (Xu et al, 2005; Rutkowski and Kaufman, 2004; 
Boyce and Yuan, 2006), before and after treatment of cells with BAPTA-AM to 
chelate Ca2+. Both in the absence and presence of BAPTA-AM, THG induced a 
similar level of ER stress in both ρ+ and ρ0 cells as shown by the magnitude in 
Bip/Grp78 and CHOP protein expression (Figures 4.6E and 4.6G). Fluo3 
fluorescence was determined by FACS analysis to ensure that the BAPTA-AM 
had chelated the Ca2+ and successfully blocked the increased cytosolic Ca2+ signal 
(Figure 4.6F). This result shows that THG treatment induced a similar level of ER 
stress in both ρ+ and ρ0 cells which was independent of Ca2+. Since ER 
cytosolic-mitochondrial Ca2+ signaling, Bax activation and the UPR was similar in 






























Figure 4.6 A Figure shows representative LSCM images of ρ+ and ρ0 cells 
loaded with DAPI, MitoTracker green and Rhod2-AM after treatment with THG ± 

























Figure 4.6 B Figure shows spectrofluorimetric traces of ρ+ and ρ0 cells loaded 
with Rhod2-AM after treatment with THG ± Ru360 as described in the Materials 





























Figure 4.6 C Figure shows bar graph of estimated Δψm of ρ+ and ρ0 cells (inset 
figure shows relative TMRM fluorescence FACS histograms of ρ+ and ρ0 cells 

























Figure 4.6 D ρ+ and ρ0 cells were treated with THG and mitochondrial and 
cytosolic fractions were harvested, separated by SDS-PAGE and Western-blotted 
for Bax as described in Materials and Methods. Bax was separated by SDS- PAGE 
























Figure 4.6 E ρ+ and ρ0 cells were treated with THG and cell lysates were 
harvested, separated by SDS-PAGE and Western-blotted for BIP/Grp78 and 






























Figure 4.6 F Representative FACS analysis histograms of Fluo3-AM-stained 
CEM cells after treatment with THG± BAPTA-AM. Thin black trace shows 
control cells; heavy black trace shows cells after treatment with THG and heavy 























Figure 4.6 G ρ+ and ρ0 cells were incubated with THG± BAPTA-AM and cell 
lysates were harvested, separated by SDS-PAGE and Western-blotted for 







4.2.7 Mitochondrial ROS do not regulate the MPT and 
apoptosis during THG-mediated ER stress 
ROS are important regulators of apoptosis (Garrido et al, 2006; Petrosillo et al, 
2003) and mitochondria are a key source of ROS production (Armstrong and 
Whiteman, 2007). Therefore, we considered that ETC derived ROS might be the 
trigger for MPT activation which would explain resistance to MPT in ρ0 cells 
which do not generate mitochondrial ROS (Armstrong and Whiteman, 2007). To 
investigate this ρ+ cells were incubated with the antioxidants N-acetyl cysteine 
(NAC) and Mn(III)tetrakis (4-benzoic acid) porphyrin chloride (MnTBAP) and 
treated with THG. Since STS-induced apoptosis is known to be regulated by ROS, 
cells were also treated with STS ± the antioxidants NAC and MnTBAP for control 
purposes (Gil et al, 2003). ρ0 cells were used to determine whether ROS were of 
mitochondrial origin (Armstrong and Whiteman, 2007). Cells were treated with 
either THG or STS ± NAC or MnTBAP and ROS production was determined by 
FACS analysis by monitoring the fluorescence of ROS-sensitive dyes DCF and 
HE (Armstrong and Whiteman, 2007). Although ROS production was observed 
after THG treatment in ρ+ cells, no ROS increase was found to occur in ρ0 cells 
indicating that the source of the ROS was the ETC (Figure 4.7A, top panels). 
Antioxidant pretreatment with NAC and MnTBAP blocked THG-induced ROS 
increase (Figure 4.7A, top panels), but did not prevent either mitochondrial 
release of OPA1 and cytochrome c, loss of Δψm, caspase 3 activation or loss of 
cell viability (Figure 4.7B, C, D and E). In contrast, ROS production was 
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observed in both ρ+ and ρ0 cells after STS treatment indicating that the source of 
the ROS was not the ETC (Figure 4.7A, bottom panels). Also, while antioxidant 
pretreatment with NAC and MnTBAP blocked STS-induced ROS increase 
(Figure 4.7A, bottom panels), it also effectively prevented the mitochondrial 
release of OPA1 and cytochrome c, loss of Δψm, caspase 3 activation and loss of 
cell viability (Figures 4.7B, C, D and E). Taken together, the results show that the 
MPT was not triggered by mitochondrial ROS and that THG-dependent apoptosis 
was not redox-regulated in contrast to STS-induced apoptosis as previously found 






































Figure 4.7 A Parental CEM cells (ρ+) were incubated with NAC (1 mM) or 
MnTBAP (50 μM) for 2 h. ρ+ and ρ0 cells were treated with THG or STS for the 
times indicated loaded with 10 μM DCFDA or 10 μM DHE for 15 min (38). DCF 
and HE fluorescence was measured by FACS analysis and quantitated (mean ± 
























Figure 4.7 B ρ+ cells were incubated with antioxidants as described above and 




























Figure 4.7 C ρ+ cells were incubated with antioxidants as described above and 
treated with THG for 36 h or STS for 9 h. Δψm was determined (results displayed 




























Figure 4.7 D ρ+ cells were incubated with antioxidants as described above and 
























Figure 4.7 E ρ+ cells were incubated with antioxidants as described above and 
both ρ+ and ρ0 cells were treated with THG for 36 h or STS for 12 h. Cell 













Figure 4.8 The MPT remodels the mitochondrial inner membrane and cristae 
junction (CJ) to allow the co-release of OPA1 and cytochrome c into the cytosol 
though a Bax pore where cytochrome c activates the canonical mitochondrial 
apoptotic pathway. The MPT is independent of VDAC in the outer membrane and 
requires a functional mitochondrial electron transport chain (ETC), but not 
mitochondrial reactive oxygen species (ROS), to activate apoptosis and therefore 















In this study, we investigated the relationship between the MPT and remodeling of 
the mitochondrial CJ for cytochrome c release and apoptosis. Three lines of 
evidence indicated that the MPT regulated CJ remodeling and cytochrome c 
release from mitochondria and that death signaling was transduced by the 
mitochondrial matrix peptidyl-prolyl isomerase (PPIase) Cyp-D (Schneider, 2005). 
First, the inhibition of mitochondrial Ca2+ uptake with the ruthenium analogue 
Ru360 prevented OPA1 and cytochrome c release from isolated mitochondria and 
mitochondria of CEM cells which blocks apoptosis (Zhang and Armstrong, 2007). 
Second, CsA which blocks the interaction of Cyp-D with the ANT (Woodfield et 
al, 1998) also prevented OPA1 and cytochrome c release from isolated 
mitochondria and mitochondria of CEM cells which blocks apoptosis (Zhang and 
Armstrong, 2007). Third, siRNA knockdown of Cyp-D also blocked OPA1 and 
cytochrome c release from mitochondria of CEM cells and prevented loss of Δψm 
and caspase 3-dependent apoptosis. These results are in agreement with the ideas 
that the MPT regulates the structural re-organization of mitochondria, in this case 
the remodeling of the CJ, in response to a Ca2+ challenge and regulates 
mitochondrial responses to cell death signals (Forte and Bernardi, 2005).  
     Although early ideas on how the MPT released cytochrome c for apoptosis 
suggested a non-specific mechanism involving organelle swelling and rupture 
(Petit et al, 1996; Green and Reed, 1998; Skulachev, 2000; Jiang et al, 2001), this 
notion is controversial since it has been found that mitochondria can release 
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cytochrome c in the absence of swelling (Gao et al, 2001; Gogvadze et al, 2004). 
An alternative idea has shown that the cytochrome c release mechanism is highly 
regulated and involves discrete steps, both at the level of the mitochondrial cristae 
and CJ, and at the mitochondrial outer membrane (Ott et al, 2002; Scorrano et al, 
2002). For example, studies have shown that cytochrome c needs to be solubilized, 
or dissociated, from other components of the ETC (Ott et al, 2002), and then 
diffuses into the intermembrane space following the structural remodeling of the 
CJ (Scorrano et al, 2002). This event is followed by a second major step requiring 
the activation and translocation to the mitochondrial outer membrane of Bcl-2 
pro-apoptotic proteins such as Bax or Bak which facilitates the release of 
cytochrome c to the cytosol for apoptosis (Zhang and Armstrong, 2007). Although, 
our results using isolated mitochondria confirm that in vitro the MPT leads to the 
release of cytochrome c, presumably by organelle rupture, as previously proposed 
(Petit et al, 1996; Green and Reed, 1998; Skulachev, 2000; Jiang et al, 2001), this 
does not appear to be the mechanism by which the MPT releases cytochrome c for 
apoptosis during ER stress since in the absence of Bax, cytochrome c was not 
released from mitochondria (Figure. 4.3C). Control experiments were performed 
to show that Bax knockdown cells were sensitive to MPT. In response to THG, 
Bax knockdown cells lost Δψm and mitochondrial cristae structure which was 
blocked by CsA (Figure 4.3B). Taken together the results are in agreement with 
the idea that mitochondrial release of cytochrome c involves two discrete steps 
including 1) activation of a Bcl-2 pro-apoptotic protein, in this case Bax, and 2) 
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structural remodeling of mitochondrial cristae.  
    The structure of the MPT has been the subject of intense investigation for a 
number of years (Bernardi et al, 2006; Armstrong, 2006). Recent genetic evidence 
has shown that mitochondria lacking all ANT isoforms were still able to undergo 
the MPT suggesting that the ANT, although still considered an MPT regulator, 
was not an essential structural component of the MPT pore (Kokoszka et al, 2004). 
Our results also indicate that the ANT is an important regulatory component of 
the MPT since its inhibition with the matrix surface inhibitor BGK effectively 
blocked the release of OPA1 and cytochrome c from isolated mitochondria and 
from mitochondria of CEM cells. Similarly, the role of the VDAC as a structural 
component of the MPT has been under scrutiny since it was shown that Cyp-D 
bound to complexes of the ANT and VDAC (Crompton et al, 1998). However, our 
results indicate, at least in isolated mitochondria, that the MPT is exclusively an 
inner membrane phenomenon and remodeling of the CJ for cytochrome c release 
occurs independently of the VDAC channel, as well as the outer membrane, in 
agreement with recent genetic evidence showing that VDACs are not structural 
components of the MPT (Baines et al, 2007).  
    Previous reports have clearly shown that the mitochondrial ETC is 
dispensable for apoptosis (Jacobson et al, 1993; Jiang et al, 1999); however, these 
studies used STS as the apoptotic stimulus and it is known that STS-induced 
apoptosis is Cyp-D independent and, therefore, not regulated by the 
MPT(Nakagawa et al, 2005; Baines et al, 2005). Also, previous reports have 
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found that the MPT is regulated by complexes I and III of the ETC (Fontaine et al, 
1999; Armstrong and Jones, 2002). Thus, we investigated a possible role for the 
ETC in regulation of the MPT during ER stress. CEM ρ0 cells, lacking a 
functional ETC (Chua et al, 2005), were resistant to the release of OPA1 and 
cytochrome c and did not undergo apoptosis indicating that electron transport was 
necessary for MPT activation. However, ρ0 cells are known to possess a 
significantly lower Δψm compared to parental cells (Appleby et al, 1999) which 
could desensitize the MPT by decreasing electrophoretic uptake of Ca2+ by the 
uniporter. Thus, we compared THG-induced mitochondrial Ca2+ levels in both ρ+ 
and ρ0 cells. We also considered that differences in Bax activation and the UPR 
could account for differences in sensitivity of the ρ0 cells to THG-induced 
apoptosis. Therefore, we compared Bax activation and translocation to 
mitochondria and the induction of Bip/GRP78 (Xu et al, 2005; Rutkowski et al, 
2004; Boyce et al, 2006), and the transcription factor CHOP (Yamaguchi et al, 
2004) in ρ+ and ρ0 cells (Figures. 4.6D, 4.6E and 4.6G). We found that there was 
no significant difference in mitochondrial Ca2+ levels after THG treatment using 
two independent measures for monitoring mitochondrial Ca2+ levels including 
LSCM, fluorescence spectrofluorimetry analysis (Figures. 4.6A and 4.6B). 
Furthermore, semiquantitative estimation of the Δψm of ρ0 cells, which is required 
to drive the Ca2+ uniporter, indicated a Δψm of ~110 mV compared to an idealized 
estimate of 130 mV for parental CEM cells (Esposti et al, 2001) (Figure 4.6C). 
Since Ca2+ uptake by the uniporter reaches a plateau at approximately 110mV 
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(Crompton, 1999) suggests that Ca2+ uptake in these cells was not limiting and, 
thus, could not explain failure to undergo MPT in response to THG treatment. 
Although, ρ0 cells were slightly resistant to STS-induced release of cytochrome c 
compared to ρ+ cells (Figure 4.5C) we considered that this could be the result of 
increased antioxidant defenses that ρ0 cells possess (Park et al, 2004; Vergani et al, 
2004). This property, however, was not considered responsible for lack of 
apoptosis in ρ0 cells treated with THG since both ρ+ and ρ0 cells were equally 
sensitive to STS-induced apoptosis (Figure 4.5D).  
    Since the MPT is known to be regulated by ROS (Orrenius et al, 2007; 
Kowaltowski et al, 2001), we determined whether THG treatment increased ROS 
production in CEM cells. Using two different ROS sensitive probes, including 
DHE for superoxide anion and DCF for GSH oxidation and hydrogen peroxide 
(H2O2) (Armstrong and Whiteman, 2007), we observed rapid ROS production 
over four hours in response to THG treatment. The ROS source was considered to 
be mitochondrial because ROS production was absent in ρ0 cells (Armstrong and 
Whiteman, 2007). Although antioxidant treatment abolished ROS production, it 
did not prevent sensitivity to MPT activation and induction of apoptosis by THG. 
Since ROS, especially H2O2 (Kim et al, 2006), and Ca2+ (Zhang and Armstrong, 
2007; Bernardi et al, 2006; Armstrong, 2006) are both known to be activators of 
the MPT, our results suggest possible differences in the MPT trigger mechanism 
in different settings. For example, in ischemia and reperfusion injury, ROS are 
crucial activators of the MPT, while Ca2+ is not considered to be involved. In 
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summary, we show that the MPT regulates the structural remodeling of the CJ 
allowing cytochrome c release for apoptosis during ER stress. This process is 
dependent on a functional ETC but does not depend on mitochondrial ROS 
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Recognition that mitochondria could release factors that could initiate cell 
death, and that at least one of these factors, cytochrome c, was sufficient for the 
latter steps of cell death, highlighted the potential gatekeeper role of mitochondria 
in cell death cascades. The mitochondrial permeability transition (MPT) plays a 
pivotal role in regulation of release of cytochrome c. The MPT refers to an 
increase of mitochondrial inner membrane permeability to solutes with molecular 
masses up to about 1500 Da. However, the exact role of the MPT in cell death and 
mechanism whereby the MPT regulates release of cell death factors are still 
elusive. To establish a comprehensive view of how occurrence of the MPT affects 
cell death, molecules that are involved in it should be identified, and detailed 
subsequent steps initiated by the MPT should be investigated. This thesis 
describes a series of studies in investigating detailed mechanisms directed towards 
these goals. Important and original observations from this study have been 
revealed to help us to understand this phenomenon deeply. 
  In this study we have investigated the mitochondrial mechanism(s) 
regulating cytochrome c release and apoptosis during ER-stress induced by THG, 
a SERCA-ATPase inhibitor, in human leukemic CEM cells. Our results indicate 
that one of the pro-apoptotic Bcl-2 family members, Bax, is required for THG 
induced apoptosis in CEM cells. Small interfering RNA (siRNA) knockdown of 
Bax blocks release of cytochrome c into the cytosol, indicating that activated Bax 
following targeting to mitochondria forms a pore which is required for 
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cytochrome c to exit. In the presence of Bax, THG induces caspase-dependent cell 
death which is inhibited by pan caspase inhibitor, zVAD-fmk. In the absence of 
Bax, the MPT initiated by THG finally leads to cell death in a 
caspase-independent manner. These results show that ER-stress-induced cell death 
involves a caspase and Bax-dependent pathway as well as a caspase-independent 
MPT-directed pathway.  
Cristae remodeling is another key event regulating cytochrome c release. 
Cristae remodeling is a result of mitochondrial dynamic reorganization which is 
controlled by continuous interplay of mitochondrial fission and fusion. In 
response to stimuli that cause fission, Drp1 translocates to mitochondria and 
interacts with hFis protein which will finally lead to fission and even 
fragmentation of mitochondria. In contrast to fission process, mitochondrial inner 
membrane fusion is regulated by OPA1. OPA1 takes responsibility for controlling 
the fusion of mitochondrial inner membrane and a recent study provided evidence 
that OPA1 maintains the integrity of cristae junctions by forming complexes 
between inner membrane-bound OPA1 and short form of the same protein which 
was cleaved by rhomboid protease, PARL. Pioneering study of mitochondrial 
structures carried out by Mannella and co-workers using electron tomography 
revealed that mitochondrial cristae form a pleomorphic, tubular-like compartment 
with a narrow neck called cristae junctions connecting to the inner membrane and 
majority of cytochrome c is stored in this compartment. In this thesis, we use a 
MPT model to further study subsequent events after MPT activation and the 
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relationship between MPT and mitochondrial cristae remodeling which has been 
implicated to be crucial for cytochrome c release and apoptosis. Since the majority 
portion of cytochrome c in the intra-cristae is critical, the mechanism governing 
egress of them is quite important. In fact, cristae junctions serve as a barrier to 
limit mobilization of this majority cytochrome c. The cumulative study has 
proposed that OPA1 is involved in maintaining the tightness of cristae junctions 
and loss of OPA1 disturbs the structure of cristae and therefore release of 
cytochrome c into cytosol, suggesting loss of OPA1 and cristae remodeling are 
concomitant events. However, the precise mechanism underlying release of OPA1 
is still elusive. In this study our observation indicates that MPT activation results 
in release of OPA1 and subsequently cristae remodeling. We presented three 
independent lines of evidence showing a key role of MPT in regulating OPA1 
release and subsequently release of cytochrome c: 1) siRNA knockdown of Cyp-D 
2) CsA, the classical MPT inhibitor and 3) pharmacological inhibition of 
mitochondrial Ca2+ overload (using Ru360 to block uniporter function) all blocked 
OPA1 and cytochrome c release. These results indicate that MPT activation was 
required for release of OPA1 and its accompanying event, cristae remodeling 
which subsequently leads to release of cytochrome c.  
Another significant finding in this study is that functional ETC is required 
for MPT activation. Concordant with the notion that mitochondrial ROS 
generation induced by THG is not responsible for the induction of apoptosis, we 
did not observe any protective effects of antioxidants on cell death mediated by 
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THG. In addition, other death signal pathways were also conserved. Our data 
indicated that ER-stress sensitivity, Bax signaling and ER-mitochondrial calcium 
signaling was not significantly altered between ρ0 cells and ρ+ cells. These results 
suggest that the electron transport chain per se, rather than the ROS produced as a 
byproduct of the ETC, was the cause for THG-mediated MPT activation and 
apoptosis in CEM cells, we next employ ρ0 cells to investigate the exact role of 
functional ETC in MPT activation. ρ0 cells serve as a useful tool to investigate 
specific cellular processes including apoptosis. Our results, showing that CEM ρ0 
cells are significantly more resistant to THG-mediated apoptosis than parental ρ+ 
cells, provide evidence that an intact respiratory chain is required for MPT 
activation, OPA1 release and its accompanying cristae remodeling, cytochrome c 
release and subsequent caspase activation. Cells lacking mitochondrial DNA may 
still undergo apoptosis as efficient as their parental cells in response to specific 
stimuli including staurosporine (STS). On the other hand, studies indicated that ρ0 
cells were resistant to apoptosis. To explain this dichotomy, we first investigated 
the difference in apoptotic stimuli induced by THG and STS. By using siRNA 
approaches to knockdown Cyp-D, component of MPT, we found that THG 
induced apoptosis in CEM cells involving MPT activation but the apoptosis 
induced by STS was not related to MPT as siRNA knockdown Cyp-D did not 
prevent dissipation of Δψm and cytochrome c release caused by STS. These results 
suggested that functional ETC can sensitize and be required for the signal for 
MPT activation. 
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The studies described in this thesis are among the first efforts to 
comprehensively and deeply clarify the detailed mechanism whereby the MPT is 
involved in regulation release of pro-cell death factors from mitochondria. In this 
thesis, we present several lines of evidence to indicate that MPT activation 
induced by THG results in the release of OPA1 which is required to maintain the 
integrity of cristae junctions. Loss of OPA1 leads to cristae remodeling and 
subsequently release of the majority fraction of cytochrome c from cristae 
compartment. Furthermore, we demonstrated that the Cyp-D dependent MPT 
activation induced by THG requires functional ETC to be involved, suggestive of 
another site for regulation of the MPT. The study in this thesis will provide 
therapeutic approaches for identification of novel high-affinity MPT inhibitors, 
which represent promising tools towards the completely controlling the MPT.  
 
